JNK3
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | S444 | Sugiyama | SHTN1 KIAA1598 | RPVNQTARPKTKPESSKGCEsAVDELKGILGtLNKSTSSRs |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00151 | S130 | Sugiyama | PDLIM1 CLIM1 CLP36 | PQEVLHIGsAHNRsAMPFtAsPAsSTTARVItNQyNNPAGL |
| O00151 | S90 | Sugiyama | PDLIM1 CLIM1 CLP36 | IKGCTDNLtLtVARsEHKVWsPLVtEEGKRHPYKMNLASEP |
| O00232 | S335 | Sugiyama | PSMD12 | MRWSTLVEDYGMELRKGsLEsPAtDVFGsTEEGEKRWKDLK |
| O00429 | S126 | Sugiyama | DNM1L DLP1 DRP1 | EIRQEIENETERISGNNKGVsPEPIHLKIFSPNVVNLTLVD |
| O14545 | S327 | Sugiyama | TRAFD1 FLN29 | DHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQNFLQQAAS |
| O14672 | S630 | Sugiyama | ADAM10 KUZ MADM | TGSVQWSRHFSGRTITLQPGsPCNDFRGYCDVFMRCRLVDA |
| O15085 | S1452 | Sugiyama | ARHGEF11 KIAA0380 | LTLKLNRLKDMELAHRELLKsLGGEssGGttPVGSFHTEAA |
| O15085 | S1457 | Sugiyama | ARHGEF11 KIAA0380 | NRLKDMELAHRELLKsLGGEssGGttPVGSFHTEAARWTDG |
| O15085 | S1458 | Sugiyama | ARHGEF11 KIAA0380 | RLKDMELAHRELLKsLGGEssGGttPVGSFHTEAARWTDGs |
| O15372 | S183 | Sugiyama | EIF3H EIF3S3 | SLKAYRLTPKLMEVCKEKDFsPEALKKANITFEYMFEEVPI |
| O43521 | S59 | SIGNOR|EPSD | BCL2L11 BIM | EPQGNPEGNHGGEGDSCPHGsPQGPLAPPAsPGPFATRsPL |
| O43521 | S69 | SIGNOR|EPSD | BCL2L11 BIM | GGEGDSCPHGsPQGPLAPPAsPGPFATRsPLFIFMRRSsLL |
| O43521 | S77 | SIGNOR | BCL2L11 BIM | HGsPQGPLAPPAsPGPFATRsPLFIFMRRSsLLSRsssGYF |
| O43521 | T116 | SIGNOR | BCL2L11 BIM | YFsFDTDRsPAPMSCDKSTQtPsPPCQAFNHYLSAMASMRQ |
| O43765 | S77 | Sugiyama | SGTA SGT SGT1 | TLPEIFEAAATGKEMPQDLRsPARtPPsEEDsAEAERLKTE |
| O43765 | T81 | Sugiyama | SGTA SGT SGT1 | IFEAAATGKEMPQDLRsPARtPPsEEDsAEAERLKTEGNEQ |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60271 | T226 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | IFPLPAGDGLLtPDAQKGGEtPGsEQWKFQELsQPRsHtsL |
| O60282 | S176 | SIGNOR | KIF5C KIAA0531 NKHC2 | VHEDKNRVPYVKGCTERFVSsPEEVMDVIDEGKANRHVAVT |
| O60333 | T647 | Sugiyama | KIF1B KIAA0591 KIAA1448 | GKNHVFRFNHPEQARAEREKtPsAEtPsEPVDWTFAQRELL |
| O60333 | T652 | Sugiyama | KIF1B KIAA0591 KIAA1448 | FRFNHPEQARAEREKtPsAEtPsEPVDWTFAQRELLEKQGI |
| O60568 | S367 | Sugiyama | PLOD3 | WPQLQDHFSAVKLVGPEEALsPGEARDMAMDLCRQDPECEF |
| O60701 | T185 | Sugiyama | UGDH | EGTAIKDLKNPDRVLIGGDEtPEGQRAVQALCAVYEHWVPR |
| O75179 | Y2038 | Sugiyama | ANKRD17 GTAR KIAA0697 | SNNNTAPTNATYPMPTAKEHyPVssPssPsPPAQPGGVsRN |
| O75391 | S158 | Sugiyama | SPAG7 | LKELAQRQEEEAAQQGPVVVsPAsDyKDKYSHLIGKGAAKD |
| O75822 | T109 | Sugiyama | EIF3J EIF3S1 PRO0391 | KKRQEEIKKRLEEPEEPKVLtPEEQLADKLRLKKLQEEsDL |
| O95067 | S392 | Sugiyama | CCNB2 | KLLKISMIPQLNSKAVKDLAsPLIGRs______________ |
| O95359 | S2512 | Sugiyama | TACC2 | KQDYPQPSDLSTFVNETKFssPtEELDyRNsYEIEyMEKIG |
| O95644 | S172 | SIGNOR|EPSD|PSP | NFATC1 NFAT2 NFATC | PstATLSLPsLEAYRDPsCLsPAssLSSRSCNSEAsSYESN |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S319 | Sugiyama | LDHA PIG19 | GISDLVKVTLtsEEEARLKKsADtLWGIQKELQF_______ |
| P00367 | T409 | Sugiyama | GLUD1 GLUD | TKSNAPRVKAKIIAEGANGPttPEADKIFLERNIMVIPDLY |
| P00367 | T410 | Sugiyama | GLUD1 GLUD | KSNAPRVKAKIIAEGANGPttPEADKIFLERNIMVIPDLYL |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P01106 | S77 | PSP | MYC BHLHE39 | PPAPSEDIWKKFELLPtPPLsPsRRsGLCsPSyVAVTPFsL |
| P01106 | S86 | PSP | MYC BHLHE39 | KKFELLPtPPLsPsRRsGLCsPSyVAVTPFsLRGDNDGGGG |
| P01106 | T73 | PSP | MYC BHLHE39 | SELQPPAPSEDIWKKFELLPtPPLsPsRRsGLCsPSyVAVT |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05067 | T743 | GPS6|SIGNOR | APP A4 AD1 | LKKKQYtsIHHGVVEVDAAVtPEERHLSKMQQNGyENPtyK |
| P05198 | T279 | Sugiyama | EIF2S1 EIF2A | KEKIEEKRGVFNVQMEPKVVtDtDEtELARQMERLERENAE |
| P05387 | S29 | Sugiyama | RPLP2 D11S2243E RPP2 | LAALGGNssPsAKDIKKILDsVGIEADDDRLNKVIsELNGK |
| P05412 | S63 | SIGNOR | JUN | ADPVGSLKPHLRAKNsDLLtsPDVGLLKLAsPELERLIIQS |
| P05412 | S73 | SIGNOR | JUN | LRAKNsDLLtsPDVGLLKLAsPELERLIIQSSNGHItttPt |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06744 | S455 | Sugiyama | GPI | ALMRGKSTEEARKELQAAGKsPEDLERLLPHKVFEGNRPTN |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07686 | T307 | Sugiyama | HEXB HCC7 | PEFDTPGHTLSWGKGQKDLLtPCySRQNKLDSFGPINPTLN |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07737 | Y60 | Sugiyama | PFN1 | FVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQ |
| P07741 | S30 | Sugiyama | APRT | EQRIRsFPDFPTPGVVFRDIsPVLKDPASFRAAIGLLARHL |
| P07814 | S886 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPEAKVLFD |
| P07814 | T737 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRV |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07942 | S1237 | Sugiyama | LAMB1 | RETVDsVERKVSEIKDILAQsPAAEPLKNIGNLFEEAEKLI |
| P07942 | T1141 | Sugiyama | LAMB1 | FWGDPDVECRACDCDPRGIEtPQCDQSTGQCVCVEGVEGPR |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08865 | T97 | Sugiyama | RPSA LAMBR LAMR1 | IssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQAAFR |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P10809 | S159 | Sugiyama | HSPD1 HSP60 | EIRRGVMLAVDAVIAELKKQsKPVttPEEIAQVAtIsANGD |
| P10809 | S175 | Sugiyama | HSPD1 HSP60 | LKKQsKPVttPEEIAQVAtIsANGDKEIGNIIsDAMKKVGR |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P10809 | T164 | Sugiyama | HSPD1 HSP60 | VMLAVDAVIAELKKQsKPVttPEEIAQVAtIsANGDKEIGN |
| P10809 | T173 | Sugiyama | HSPD1 HSP60 | AELKKQsKPVttPEEIAQVAtIsANGDKEIGNIIsDAMKKV |
| P10809 | T455 | Sugiyama | HSPD1 HSP60 | GIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLKIP |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P12270 | S2155 | Sugiyama | TPR | PstPtLVVPHRtDGFAEAIHsPQVAGVPRFRFGPPEDMPQT |
| P12277 | T35 | Sugiyama | CKB CKBB | PAEDEFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDD |
| P13639 | S595 | Sugiyama | EEF2 EF2 | PVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGLAE |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S552 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | KEKQDKIyFMAGsSRKEAEssPFVERLLKKGyEVIyLTEPV |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14866 | S101 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | GAAGGGGGGENyDDPHKtPAsPVVHIRGLIDGVVEADLVEA |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15336 | T69 | Sugiyama | ATF2 CREB2 CREBP1 | HEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELA |
| P15336 | T71 | Sugiyama | ATF2 CREB2 CREBP1 | MtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELAsP |
| P15559 | S82 | Sugiyama | NQO1 DIA4 NMOR1 | DPANFQYPAESVLAYKEGHLsPDIVAEQKKLEAADLVIFQF |
| P16278 | S434 | Sugiyama | GLB1 ELNR1 | GFVLYRTTLPQDCSNPAPLssPLNGVHDRAyVAVDGIPQGV |
| P16949 | S25 | Sugiyama | STMN1 C1orf215 LAP18 OP18 | DIQVKELEKRAsGQAFELILsPRsKEsVPEFPLsPPKKKDL |
| P16949 | S38 | SIGNOR|Sugiyama | STMN1 C1orf215 LAP18 OP18 | QAFELILsPRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAE |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17544 | T51 | Sugiyama | ATF7 ATFA | HEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELA |
| P17544 | T53 | Sugiyama | ATF7 ATFA | MTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELASS |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P20618 | S151 | Sugiyama | PSMB1 PSC5 | PYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASA |
| P21333 | S1084 | Sugiyama | FLNA FLN FLN1 | PTKPSKVKAFGPGLQGGsAGsPARFtIDTKGAGTGGLGLTV |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22314 | T233 | Sugiyama | UBA1 A1S9T UBE1 | GEQPLSAMVSMVTKDNPGVVtCLDEARHGFESGDFVSFSEV |
| P23921 | S559 | Sugiyama | RRM1 RR1 | ALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTPTDLW |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27816 | S280 | Sugiyama | MAP4 | LAKDMALATKTEVALAKDMEsPtKLDVtLAKDMQPSMESDM |
| P28074 | S175 | Sugiyama | PSMB5 LMPX MB1 X | SMGTMICGWDKRGPGLyyVDsEGNRISGATFSVGSGSVYAY |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | T287 | Sugiyama | TKT | AEQIIQEIysQIQsKKKILAtPPQEDAPsVDIANIRMPsLP |
| P29692 | S65 | Sugiyama | EEF1D EF1D | VILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRIA |
| P29966 | S27 | Sugiyama | MARCKS MACS PRKCSL | KTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsP |
| P30041 | T44 | Sugiyama | PRDX6 AOP2 KIAA0106 | RFHDFLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKR |
| P30043 | S82 | Sugiyama | BLVRB FLR SCAN | DKTVAGQDAVIVLLGTRNDLsPTTVMSEGARNIVAAMKAHG |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30050 | S165 | Sugiyama | RPL12 | GRHPHDIIDDINsGAVECPAs____________________ |
| P30050 | S26 | Sugiyama | RPL12 | DPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDDI |
| P30101 | S443 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLN |
| P30307 | S168 | SIGNOR | CDC25C | SANKENDNGNLVDSEMKYLGsPITTVPKLDKNPNLGEDQAE |
| P31943 | S104 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S186 | SIGNOR | SFN HME1 | NPIRLGLALNFSVFHYEIANsPEEAISLAKTtFDEAMADLH |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33992 | S315 | Sugiyama | MCM5 CDC46 | RVLGIQVDTDGSGRSFAGAVsPQEEEEFRRLAALPNVYEVI |
| P34897 | S417 | Sugiyama | SHMT2 | ERVLELVSITANKNTCPGDRsAItPGGLRLGAPALtSRQFR |
| P34897 | T420 | Sugiyama | SHMT2 | LELVSITANKNTCPGDRsAItPGGLRLGAPALtSRQFREDD |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P35606 | T828 | Sugiyama | COPB2 | EEWVKETHADLWPAKQyPLVtPNEERNVMEEGKDFQPSRst |
| P35998 | T193 | Sugiyama | PSMC2 MSS1 | TYSDVGGCKEQIEKLREVVEtPLLHPERFVNLGIEPPKGVL |
| P36578 | S295 | Sugiyama | RPL4 RPL1 | sNyNLPMHKMINtDLsRILKsPEIQRALRAPRKKIHRRVLK |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38936 | S130 | EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | HVDLsLSCTLVPRsGEQAEGsPGGPGDSQGRKRRQtsMTDF |
| P38936 | S98 | EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | LPtGPRRGRDELGGGRRPGtsPALLQGTAEEDHVDLsLSCT |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P41091 | T109 | Sugiyama | EIF2S3 EIF2G | YKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLVRH |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P43121 | T107 | Sugiyama | MCAM MUC18 | EYEQRLsLQDRGAtLALtQVtPQDERIFLCQGKRPRSQEYR |
| P45983 | S179 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | VKSDCTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILG |
| P45983 | T178 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | VVKSDCTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVIL |
| P45983 | T183 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | CTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYK |
| P45983 | T188 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | LDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYKENVDL |
| P45983 | T243 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | ILFPGRDYIDQWNKVIEQLGtPCPEFMKKLQPTVRTYVENR |
| P45983 | Y185 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | LKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYKEN |
| P45983 | Y190 | Sugiyama | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C | FGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYKENVDLWS |
| P45985 | T60 | Sugiyama | MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1 | KRKALKLNFANPPFKstARFtLNPNPtGVQNPHIERLRTHs |
| P45985 | T66 | Sugiyama | MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1 | LNFANPPFKstARFtLNPNPtGVQNPHIERLRTHsIEsSGK |
| P46013 | T1923 | Sugiyama | MKI67 | AMHTPKAAVGEEKDINtFVGtPVEKLDLLGNLPGsKRRPQt |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | S367 | Sugiyama | YAP1 YAP65 | ALRSQLPtLEQDGGtQNPVssPGMsQELRTMttNssDPFLN |
| P46937 | T119 | Sugiyama | YAP1 YAP65 | PEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQLGAVsP |
| P47756 | S207 | Sugiyama | CAPZB | MNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKIRst |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P49023 | S106 | Sugiyama | PXN | PVyGssAKtssVsNPQDsVGsPCsRVGEEEHVysFPNKQKs |
| P49321 | T390 | Sugiyama | NASP | EAPVLPKDGAVNGPsVVGDQtPIEPQtsIERLtEtKDGsGL |
| P49327 | S831 | Sugiyama | FASN FAS | NPNALFPPVEFPAPRGtPLIsPLIKWDHSLAWDVPAAEDFP |
| P49327 | T827 | Sugiyama | FASN FAS | GIDANPNALFPPVEFPAPRGtPLIsPLIKWDHSLAWDVPAA |
| P49448 | T409 | Sugiyama | GLUD2 GLUDP1 | TKSNAPRVKAKIIAEGANGPttPEADKIFLERNILVIPDLY |
| P49448 | T410 | Sugiyama | GLUD2 GLUDP1 | KSNAPRVKAKIIAEGANGPttPEADKIFLERNILVIPDLYL |
| P49792 | T1144 | Sugiyama | RANBP2 NUP358 | GFRRsDDMFTFHGPGKsVFGtPtLETANKNHEtDGGsAHGD |
| P50502 | S181 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | LQKPNAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| P51991 | S358 | Sugiyama | HNRNPA3 HNRPA3 | QQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF |
| P52565 | T160 | Sugiyama | ARHGDIA GDIA1 | DKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYsIKSR |
| P52948 | S623 | Sugiyama | NUP98 ADAR2 | KNLNNsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDE |
| P53779 | S217 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | VKSDCTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILG |
| P53779 | T216 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | VVKSDCTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVIL |
| P53779 | T221 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | CTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYK |
| P53779 | T226 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | LDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYKENVDI |
| P53779 | T281 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | ILFPGRDYIDQWNKVIEQLGtPCPEFMKKLQPTVRNYVENR |
| P53779 | T308 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | KKLQPTVRNYVENRPKyAGLtFPKLFPDSLFPADSEHNKLK |
| P53779 | Y223 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | LKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYKEN |
| P53779 | Y228 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | FGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYKENVDIWS |
| P53779 | Y304 | Sugiyama | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | PEFMKKLQPTVRNYVENRPKyAGLtFPKLFPDSLFPADSEH |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54259 | S739 | GPS6|SIGNOR|EPSD|PSP | ATN1 D12S755E DRPLA | PPLSATQIKQEPAEEyEtPEsPVPPARsPsPPPKVVDVPSH |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55036 | S115 | Sugiyama | PSMD4 MCB1 | LALKHRQGKNHKMRIIAFVGsPVEDNEKDLVKLAKRLKKEK |
| P55209 | T62 | Sugiyama | NAP1L1 NRP | MMQNPQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALK |
| P55795 | S104 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P55809 | S509 | Sugiyama | OXCT1 OXCT SCOT | LWEGLTVDDVQKSTGCDFAVsPKLMPMQQIAN_________ |
| P55957 | T59 | EPSD|PSP | BID | ALGHELPVLAPQWEGyDELQtDGNRssHsRLGRIEADsEsQ |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60866 | T6 | Sugiyama | RPS20 | _______________MAFKDtGKtPVEPEVAIHRIRITLTS |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61604 | S64 | Sugiyama | HSPE1 | AtVVAVGsGsKGKGGEIQPVsVKVGDKVLLPEyGGtKVVLD |
| P61916 | S40 | Sugiyama | NPC2 HE1 | EPVQFKDCGsVDGVIKEVNVsPCPtQPCQLSKGQSYSVNVT |
| P61978 | S216 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | HNRNPK HNRPK | GGKPDRVVECIKIILDLIsEsPIKGRAQPyDPNFyDETyDy |
| P61978 | S284 | SIGNOR|iPTMNet|EPSD|Sugiyama | HNRNPK HNRPK | MPPGRGGRPMPPSRRDyDDMsPRRGPPPPPPGRGGRGGsRA |
| P61978 | S353 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | HNRNPK HNRPK | YDGMVGFSADETWDSAIDtWsPSEWQMAYEPQGGSGYDYSY |
| P61981 | S38 | Sugiyama | YWHAG | ERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKNVVGARRS |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62195 | T109 | Sugiyama | PSMC5 SUG1 | VHPEGKFVVDVDKNIDINDVtPNCRVALRNDsytLHKILPN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62714 | S212 | Sugiyama | PPP2CB | EGPMCDLLWSDPDDRGGWGIsPRGAGYTFGQDISETFNHAN |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P63104 | S184 | SIGNOR | YWHAZ | HPIRLGLALNFSVFYYEILNsPEKACSLAKtAFDEAIAELD |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67775 | S212 | Sugiyama | PPP2CA | EGPMCDLLWSDPDDRGGWGIsPRGAGYTFGQDISETFNHAN |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P78347 | S210 | Sugiyama | GTF2I BAP135 WBSCR6 | EPKKHVGGRVMVtDADRsILsPGGsCGPIKVKTEPTEDSGI |
| P85037 | S420 | Sugiyama | FOXK1 MNF | RGVSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECL |
| P85037 | S428 | Sugiyama | FOXK1 MNF | PFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsREGsPIP |
| Q01082 | S2197 | Sugiyama | SPTBN1 SPTB2 | KTALPAQsAAtLPARtQEtPsAQMEGFLNRKHEWEAHNKKA |
| Q01082 | T2192 | Sugiyama | SPTBN1 SPTB2 | sDRKAKTALPAQsAAtLPARtQEtPsAQMEGFLNRKHEWEA |
| Q01814 | S1234 | Sugiyama | ATP2B2 PMCA2 | DSGINLTTDtsKSATSSsPGsPIHSLEtsL___________ |
| Q04637 | S1231 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | tEDRDRGRDAVKREAALPPVsPLKAALsEEELEKKsKAIIE |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q06481 | T736 | EPSD|PSP | APLP2 APPL2 | LRKRQYGtISHGIVEVDPMLtPEERHLNKMQNHGyENPtyK |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07866 | S460 | Sugiyama | KLC1 KLC KNS2 | QKDGTsFGEyGGWyKACKVDsPtVTTtLKNLGALyRRQGKF |
| Q08AD1 | S673 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | DASKFLQDyDIRTGNTREALsPCPsTVsTKSQPGSSAssss |
| Q08J23 | S743 | Sugiyama | NSUN2 SAKI TRM4 | AstGQPDNDVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGV |
| Q08J23 | S751 | Sugiyama | NSUN2 SAKI TRM4 | DVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGVHPPR____ |
| Q09666 | S216 | Sugiyama | AHNAK PM227 | DVEtQsGKtVIRLPsGsGAAsPtGsAVDIRAGAIsAsGPEL |
| Q09666 | S41 | Sugiyama | AHNAK PM227 | HGLTIAQRDDGVFVQEVtQNsPAARTGVVKEGDQIVGATIy |
| Q09666 | T4564 | Sugiyama | AHNAK PM227 | LEGDLKGPKVDVKGPKVGIDtPDIDIHGPEGKLKGPKFKMP |
| Q12931 | S568 | Sugiyama | TRAP1 HSP75 HSPC5 | ISVETDIVVDHYKEEKFEDRsPAAECLSEKETEELMAWMRN |
| Q13017 | S968 | Sugiyama | ARHGAP5 RHOGAP5 | SYLsDNtRESTHQSEDVFLPsPRDCFPyNNyPDsDDDtEAP |
| Q13045 | S856 | Sugiyama | FLII FLIL | KNWDDVLTVDYTRNAEAVLQsPGLsGKVKRDAEKKDQMKAD |
| Q13066 | T39 | Sugiyama | GAGE2B GAGE2; GAGE2C | PPEMIGPMRPEQFsDEVEPAtPEEGEPATQRQDPAAAQEGE |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13409 | T95 | Sugiyama | DYNC1I2 DNCI2 DNCIC2 | IVFSEYWVPPPMsPSSKsVStPsEAGsQDsGDGAVGsRTLH |
| Q13428 | T1014 | Sugiyama | TCOF1 | ARssssEsEDEDVIPAtQCLtPGIRTNVVTMPTAHPRIAPK |
| Q13451 | S13 | Sugiyama | FKBP5 AIG6 FKBP51 | ________MttDEGAKNNEEsPtAtVAEQGEDITsKKDRGV |
| Q13459 | S1308 | Sugiyama | MYO9B MYR5 | PDsPGGstQIQRYLDAERLAsAVELWRGKKLVAAAsPsAML |
| Q14103 | S190 | Sugiyama | HNRNPD AUF1 HNRPD | KRAKAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVES |
| Q14103 | T193 | Sugiyama | HNRNPD AUF1 HNRPD | KAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVESIEL |
| Q14160 | S504 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | MKRSIEGRRsEACPCQPDsGsPLPAEEEKRLsAESGLSEDS |
| Q14204 | S2410 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | GEDEAQRRRKGKEDEGEEAAsPMLQIQRDAATIMQPYFTSN |
| Q14204 | S3082 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | LHVVFTMNPSSEGLKDRAAtsPALFNRCVLNWFGDWSTEAL |
| Q14247 | S418 | Sugiyama | CTTN EMS1 | KtQtPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVs |
| Q14258 | S100 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | DLAREPPADVWtPPARAsAPsPNAQVACDHCLKEAAVKTCL |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14684 | T708 | Sugiyama | RRP1B KIAA0179 | LNRNMtAEFKKTDKsILVsPtGPsRVAFDPEQKPLHGVLKt |
| Q14847 | T104 | Sugiyama | LASP1 MLN50 | VRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsNIKyHE |
| Q14980 | S1757 | Sugiyama | NUMA1 NMP22 NUMA | ITSKLPRtQPDGtsVPGEPAsPIsQRLPPKVEsLEsLyFtP |
| Q15393 | T1200 | Sugiyama | SF3B3 KIAA0017 SAP130 | EQFNsMEPNKQKNVSEELDRtPPEVSKKLEDIRTRYAF___ |
| Q15545 | S201 | Sugiyama | TAF7 TAF2F TAFII55 | WEIIAEDETKEAENQGLDIssPGMsGHRQGHDsLEHDELRE |
| Q15637 | S80 | Sugiyama | SF1 ZFM1 ZNF162 | DLTRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFR |
| Q15642 | S298 | Sugiyama | TRIP10 CIP4 STOT STP | RPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRSRT |
| Q15773 | S238 | Sugiyama | MLF2 | GAGGRRAEGPPRLAIQGPEDsPsRQsRRYDW__________ |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16600 | S129 | GPS6 | ZNF239 HOK2 MOK2 | GESCSENLQVKLVSDGQELAsPLLNGEATCQNGQLKESLDP |
| Q16600 | S38 | GPS6 | ZNF239 HOK2 MOK2 | EVDGEPELDIsPCQQWGEAssPISRNRDsVMTLQSGCFENI |
| Q16643 | T346 | Sugiyama | DBN1 D0S117E | RRMAPtPIPtRsPsDsstAstPVAEQIERALDEVTsSQPPP |
| Q16881 | T413 | Sugiyama | TXNRD1 GRIM12 KDRF | HGIKFIRQFVPIKVEQIEAGtPGRLRVVAQSTNSEEIIEGE |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q5JR12 | S93 | SIGNOR | PPM1J PPP2CZ | LQLsPGGLRRADDHAGRAVQsPPDTGRRLPWSTGYAEVINA |
| Q5JSH3 | S96 | Sugiyama | WDR44 RPH11 | QLEDDsLDSKGKELsDQAtAsPIVARTDLSNIPGLLAIDQV |
| Q5R3I4 | S362 | Sugiyama | TTC38 | GAHDPQTTQELLTTLRDASEsPGENCQHLLARDVGLPLCQA |
| Q5T4S7 | S178 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | AKLPQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLT |
| Q5T4S7 | S181 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | PQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLTSVF |
| Q5VT52 | T723 | Sugiyama | RPRD2 KIAA0460 HSPC099 | SHPSDFQRGPtstsIDNIDGtPVRDERsGtPtQDEMMDKPt |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q66K74 | S759 | Sugiyama | MAP1S BPY2IP1 C19orf5 MAP8 VCY2IP1 | LVsPCEFEHRKAVPMAPAPAsPGssNDssARsQERAGGLGA |
| Q6EMK4 | S322 | Sugiyama | VASN SLITL2 UNQ314/PRO357/PRO1282 | CVCPLSWFGPWVRESHVTLAsPEETRCHFPPKNAGRLLLEL |
| Q6NT46 | T39 | Sugiyama | GAGE2A GAGE2 | PPEMIGPMRPEQFsDEVEPAtPEEGEPATQRQDPAAAQEGQ |
| Q6NZY4 | S598 | Sugiyama | ZCCHC8 | LDEPEVPEIFTKKsEAGHAssPDsEVTsLCQKEKAELAPVN |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6XQN6 | S513 | Sugiyama | NAPRT FHIP NAPRT1 | SRALAQLsLSRLSPEHRRLRsPAQYQVVLSERLQALVNSLC |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q7L2J0 | S216 | Sugiyama | MEPCE BCDIN3 | NLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDIt |
| Q7L2J0 | S217 | Sugiyama | MEPCE BCDIN3 | LNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDItD |
| Q7L2J0 | T213 | Sugiyama | MEPCE BCDIN3 | DPLNLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPK |
| Q7Z417 | S692 | Sugiyama | NUFIP2 KIAA1321 PIG1 | IWNLQKQDPKRIItyNEAMDsPDQ_________________ |
| Q7Z5K2 | T388 | Sugiyama | WAPL FOE KIAA0261 WAPAL | VCNVTIQDTMERsMDEFTAstPADLGEAGRLRKKADIATSK |
| Q7Z6Z7 | T2889 | Sugiyama | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | EAVGDTSAAGSSEQPRAGsstPGDAPPAVAEVQGRSDGsGE |
| Q86UE4 | T143 | Sugiyama | MTDH AEG1 LYRIC | SEKPKPNGRTVEVAEGEAVRtPQsVtAKQPPEIDKKNEKSK |
| Q8N1F7 | S430 | Sugiyama | NUP93 KIAA0095 | TEDYLWLKLNQVCFDDDGTssPQDRLTLsQFQKQLLEDYGE |
| Q8N556 | S265 | Sugiyama | AFAP1 AFAP | KEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssDG |
| Q8N684 | S205 | Sugiyama | CPSF7 | IPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLPYF |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NBJ7 | T278 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | IDtADGsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPP |
| Q8NEY1 | S1000 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | PsPPALPMSLSAKGQLTNIVsPtAAttPRITRsNsIPTHEA |
| Q8NEY1 | T1006 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | PMSLSAKGQLTNIVsPtAAttPRITRsNsIPTHEAAFELYS |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8NFI4 | S181 | Sugiyama | ST13P5 FAM10A5 | LQKPNAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| Q8TB72 | S82 | Sugiyama | PUM2 KIAA0235 PUMH2 | MVQRRsGQGFHGNsEVNAILsPRsEsGGLGVsMVEYVLsss |
| Q8TCS8 | S754 | Sugiyama | PNPT1 PNPASE | KYFGRDPADGRMRLSRKVLQsPAtTVVRTLNDRssIVMGEP |
| Q8WUF5 | S567 | Sugiyama | PPP1R13L IASPP NKIP1 PPP1R13BL RAI | ISRLFHRHGGPGPGGPEPELsPItEGSEARAGPPAPAPPAP |
| Q8WUI4 | S109 | Sugiyama | HDAC7 HDAC7A | LAEVILKKQQAALERtVHPNsPGIPYRTLEPLETEGATRSM |
| Q8WWM7 | S111 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | PGAAAIGsARGQstGKGPPQsPVFEGVyNNSRMLHFLTAVV |
| Q8WXI9 | S135 | Sugiyama | GATAD2B KIAA1150 | ERGRLtPsPDIIVLsDNEAssPRsSsRMEERLKAANLEMFK |
| Q8WXI9 | T120 | Sugiyama | GATAD2B KIAA1150 | INDEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSs |
| Q92530 | S152 | Sugiyama | PSMF1 | SRIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIP |
| Q92530 | S153 | Sugiyama | PSMF1 | RIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIPP |
| Q92688 | S104 | Sugiyama | ANP32B APRIL PHAPI2 | AEKLPNLTHLNLsGNKLKDIstLEPLKKLECLKsLDLFNCE |
| Q92688 | T105 | Sugiyama | ANP32B APRIL PHAPI2 | EKLPNLTHLNLsGNKLKDIstLEPLKKLECLKsLDLFNCEV |
| Q92945 | S184 | Sugiyama | KHSRP FUBP2 | GEQINKIQQDSGCKVQIsPDsGGLPERsVsLtGAPEsVQKA |
| Q93045 | S62 | SIGNOR | STMN2 SCG10 SCGN10 | VKQINKRAsGQAFELILKPPsPISEAPRTLAsPKKKDLsLE |
| Q93045 | S73 | SIGNOR | STMN2 SCG10 SCGN10 | AFELILKPPsPISEAPRTLAsPKKKDLsLEEIQKKLEAAEE |
| Q969R2 | S762 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | AHYVLSGSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSA |
| Q969R2 | S763 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | HYVLSGSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSAK |
| Q969R2 | S766 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | LSGSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSAKLLW |
| Q969R2 | S768 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | GSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSAKLLWKK |
| Q96AE4 | S140 | Sugiyama | FUBP1 | GEQISRIQQESGCKIQIAPDsGGLPERsCMLtGtPESVQSA |
| Q96AE4 | S630 | Sugiyama | FUBP1 | DYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ______ |
| Q96AG4 | S47 | Sugiyama | LRRC59 PRO1855 | LNEVPVKELAALPKATILDLsCNKLTTLPSDFCGLtHLVKL |
| Q96B36 | S212 | Sugiyama | AKT1S1 PRAS40 | GFKEKRtEARssDEENGPPssPDLDRIAAsMRALVLREAED |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96D15 | T72 | Sugiyama | RCN3 UNQ239/PRO272 | FQYDHEAFLGREVAKEFDQLtPEEsQARLGRIVDRMDRAGD |
| Q96G03 | S186 | Sugiyama | PGM2 MSTP006 | HNPKQDNGYKVyWDNGAQIIsPHDKGISQAIEENLEPWPQA |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96K76 | S910 | Sugiyama | USP47 | DGDNGDssKstEtsDFENIEsPLNERDsSAsVDNRELEQHI |
| Q9BQ16 | T118 | Sugiyama | SPOCK3 TICN3 UNQ409/PRO771 | HKVCIAQDSQTAVCISHRRLtHRMKEAGVDHRQWRGPILST |
| Q9BX68 | T47 | Sugiyama | HINT2 | QVRGAAGVTDGNEVAKAQQAtPGGAAPtIFsRILDKsLPAD |
| Q9BYN0 | T133 | Sugiyama | SRXN1 C20orf139 SRX SRX1 | IPAKLVQSTLSDLRVYLGAStPDLQ________________ |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S1297 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GQADWtPDLGLRNMAPGAVCsPGEsKELGVGQMDWGNNLGL |
| Q9C0C2 | S435 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | DAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQG |
| Q9C0C2 | S494 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QSFEWTFPTRPSGLGVWRLDsPPPsPItEAsEAAEAAEAGN |
| Q9C0C2 | S498 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | WTFPTRPSGLGVWRLDsPPPsPItEAsEAAEAAEAGNLAVS |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9C0C2 | S712 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | PPPsGGGARRGAGAELKDtQsPstCsEGLLGWsQKDLQSEF |
| Q9C0C2 | S717 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GGARRGAGAELKDtQsPstCsEGLLGWsQKDLQSEFGITGD |
| Q9C0C2 | T715 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | sGGGARRGAGAELKDtQsPstCsEGLLGWsQKDLQSEFGIT |
| Q9H078 | S668 | Sugiyama | CLPB SKD3 | TLRITVEDSDKQLLKsPELPsPQAEKRLPKLRLEIIDKDSK |
| Q9H0B6 | S445 | Sugiyama | KLC2 | RRDsAPyGEyGsWYKACKVDsPtVNTTLRSLGALYRRQGKL |
| Q9H0L4 | T570 | Sugiyama | CSTF2T KIAA0689 | GASKQGGsQPssFsPGQsQVtPQDQEKAALIMQVLQLTADQ |
| Q9H2U2 | S313 | Sugiyama | PPA2 HSPC124 | VQISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLG |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H6F5 | S80 | Sugiyama | CCDC86 CYCLON | ERPPKtsPGsPRLQQGAGLEsPQGQPEPGAAsPQRQQDLHL |
| Q9H8Y8 | S432 | Sugiyama | GORASP2 GOLPH6 | VDVtPPtAKAPttVEDRVGDstPVsEKPVsAAVDANAsEsP |
| Q9H8Y8 | S441 | Sugiyama | GORASP2 GOLPH6 | APttVEDRVGDstPVsEKPVsAAVDANAsEsP_________ |
| Q9HBL0 | S858 | Sugiyama | TNS1 TNS | NMLMLDLEPASAAAPLHKSQsVPGAWPGASPLSSQPLSGSS |
| Q9HCD6 | S169 | Sugiyama | TANC2 KIAA1148 KIAA1636 | tLPPISTNATAKDCSyGAVtsPtstLESRDSGIIATLTSYS |
| Q9HDC9 | T190 | Sugiyama | APMAP C20orf3 UNQ1869/PRO4305 | KGLFEVNPWKREVKLLLSsEtPIEGKNMSFVNDLTVTQDGR |
| Q9NPI6 | S523 | Sugiyama | DCP1A SMIF | APSVFQQTVTRSSDLERKAssPsPLtIGtPEsQRKPSIILS |
| Q9NPI6 | T528 | Sugiyama | DCP1A SMIF | QQTVTRSSDLERKAssPsPLtIGtPEsQRKPSIILSKsQLQ |
| Q9NPI6 | T531 | Sugiyama | DCP1A SMIF | VTRSSDLERKAssPsPLtIGtPEsQRKPSIILSKsQLQDTL |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NSK0 | S460 | Sugiyama | KLC4 KNSL8 | HEGGtPYAEYGGWYKACKVssPTVNTTLRNLGALyRRQGKL |
| Q9NZB2 | S990 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | FPLQVVSVGGPARGRPRGVIstPVIRTFGRGGRYYGRGYKN |
| Q9NZT2 | S378 | Sugiyama | OGFR | LERsQGDEAGGHGEDRPEPLsPKEsKKRKLELSRREQPPTE |
| Q9P2J9 | S118 | Sugiyama | PDP2 KIAA1348 | LESRVPNSVLRFESNQLAANsPVEDRRGVASCLQTNGLMFG |
| Q9UGV2 | S361 | Sugiyama | NDRG3 | sPFsRsVtsNQsDGtQESCEsPDVLDRHQTMEVsC______ |
| Q9UHB6 | S490 | Sugiyama | LIMA1 EPLIN SREBP3 PP624 | ENEEILERPAQLANAREtPHsPGVEDAPIAKVGVLAAsMEA |
| Q9UKS6 | S319 | Sugiyama | PACSIN3 | FEEWsLDtQRtIsRKEKGGRsPDEVtLtsIVPTRDGTAPPP |
| Q9ULD2 | S1264 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | RsPtssAIPLQsPRNsGsFPsPsIsPR______________ |
| Q9ULD2 | S1268 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | ssAIPLQsPRNsGsFPsPsIsPR__________________ |
| Q9UPT6 | T265 | SIGNOR|iPTMNet | MAPK8IP3 JIP3 KIAA1066 | SSYQCPQDEMSESGQSSAAAtPSTTGTKsNtPtssVPSAAV |
| Q9UPT6 | T275 | SIGNOR|iPTMNet | MAPK8IP3 JIP3 KIAA1066 | SESGQSSAAAtPSTTGTKsNtPtssVPSAAVtPLNESLQPL |
| Q9UPT6 | T286 | SIGNOR|iPTMNet | MAPK8IP3 JIP3 KIAA1066 | PSTTGTKsNtPtssVPSAAVtPLNESLQPLGDYGVGSKNSK |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2272 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | tAVNLADsRtPAAAAAMNLAsPRtAVAPsAVNLADPRtPtA |
| Q9UQ35 | T383 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PPAPtPLLAERHGGsPQPLAttPLsQEPVNPPsEAsPtRDR |
| Q9UQF2 | T103 | GPS6 | MAPK8IP1 IB1 JIP1 PRKM8IP | AGSRLQAEMLQMDLIDATGDtPGAEDDEEDDDEERAARRPG |
| Q9UQF2 | T205 | GPS6 | MAPK8IP1 IB1 JIP1 PRKM8IP | KHSWQDRVSRSSsPLKTGEQtPPHEHICLSDELPPQSGPAP |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
| Q9Y2W2 | S237 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | RKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDDG |
| Q9Y2X7 | S362 | Sugiyama | GIT1 | TLIIDILSEAKRRQQGKsLssPtDNLELsLRSQSDLDDQHD |
| Q9Y5M8 | S257 | Sugiyama | SRPRB PSEC0230 | LPLKVEFLECSAKGGRGDVGsADIQDLEKWLAKIA______ |
| Q9Y6G9 | S516 | Sugiyama | DYNC1LI1 DNCLI1 | HAELDRITRKPVtVsPttPtsPtEGEAs_____________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 2.935932e-07 | 6.532 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.158156e-06 | 5.381 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.237655e-06 | 5.205 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.048046e-05 | 4.980 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.404918e-05 | 4.130 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.772664e-05 | 4.010 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 9.855458e-05 | 4.006 | 1 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.598963e-04 | 3.796 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.691800e-04 | 3.772 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.256836e-04 | 3.647 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.256836e-04 | 3.647 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.236468e-04 | 3.650 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.518368e-04 | 3.599 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.870135e-04 | 3.542 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.140371e-04 | 3.503 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.184851e-04 | 3.378 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 5.148591e-04 | 3.288 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.086220e-04 | 3.294 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.243926e-04 | 3.280 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.003654e-04 | 3.155 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.913415e-04 | 3.050 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.932193e-04 | 3.049 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.359312e-04 | 3.078 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.622467e-04 | 3.064 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.363181e-03 | 2.865 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.485411e-03 | 2.828 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.331371e-03 | 2.876 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.033697e-03 | 2.986 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.485411e-03 | 2.828 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.066221e-03 | 2.972 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.628662e-03 | 2.788 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.631214e-03 | 2.787 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.596382e-03 | 2.797 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.760205e-03 | 2.754 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.366943e-03 | 2.626 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.366943e-03 | 2.626 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.452703e-03 | 2.610 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.681948e-03 | 2.572 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.536593e-03 | 2.451 | 1 | 1 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.670453e-03 | 2.435 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.787589e-03 | 2.422 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.166054e-03 | 2.380 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.253813e-03 | 2.371 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.252764e-03 | 2.371 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.451670e-03 | 2.351 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.346227e-03 | 2.362 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.460207e-03 | 2.351 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.414356e-03 | 2.266 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.414356e-03 | 2.266 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.340771e-03 | 2.272 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.450019e-03 | 2.264 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.733939e-03 | 2.242 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.492217e-03 | 2.260 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.492217e-03 | 2.260 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.181874e-03 | 2.209 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.866208e-03 | 2.163 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.866208e-03 | 2.163 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.932545e-03 | 2.159 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.932545e-03 | 2.159 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.866208e-03 | 2.163 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.866208e-03 | 2.163 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.741787e-03 | 2.171 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.027683e-03 | 2.153 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.069507e-03 | 2.151 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.653845e-03 | 2.116 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.672798e-03 | 2.115 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.296014e-03 | 2.081 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 8.940223e-03 | 2.049 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 9.326852e-03 | 2.030 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 9.326852e-03 | 2.030 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.110723e-02 | 1.954 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.110723e-02 | 1.954 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.110723e-02 | 1.954 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 9.834810e-03 | 2.007 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.006682e-02 | 1.997 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.834810e-03 | 2.007 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.048219e-02 | 1.980 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.110723e-02 | 1.954 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.128518e-02 | 1.947 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.144841e-02 | 1.941 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.155894e-02 | 1.937 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.231528e-02 | 1.910 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.347789e-02 | 1.870 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.347789e-02 | 1.870 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.346626e-02 | 1.871 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.283177e-02 | 1.892 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.259069e-02 | 1.900 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.353732e-02 | 1.868 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.353732e-02 | 1.868 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.390931e-02 | 1.857 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.400147e-02 | 1.854 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.432646e-02 | 1.844 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.527684e-02 | 1.816 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.527684e-02 | 1.816 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.560058e-02 | 1.807 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.590778e-02 | 1.798 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.552179e-02 | 1.809 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.685770e-02 | 1.773 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.920859e-02 | 1.717 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.920859e-02 | 1.717 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.962635e-02 | 1.707 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.126740e-02 | 1.672 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.126740e-02 | 1.672 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.078079e-02 | 1.682 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.141150e-02 | 1.669 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.048962e-02 | 1.688 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.141150e-02 | 1.669 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.013046e-02 | 1.696 | 0 | 0 |
| RSK activation | R-HSA-444257 | 2.158818e-02 | 1.666 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.228863e-02 | 1.652 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.277940e-02 | 1.642 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.289782e-02 | 1.640 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.478886e-02 | 1.606 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.483767e-02 | 1.605 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.490688e-02 | 1.604 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.519233e-02 | 1.599 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.631579e-02 | 1.580 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.889313e-02 | 1.539 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.889313e-02 | 1.539 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.889313e-02 | 1.539 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.757733e-02 | 1.559 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.631579e-02 | 1.580 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.902594e-02 | 1.537 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.942514e-02 | 1.531 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.953607e-02 | 1.530 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.953607e-02 | 1.530 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.303089e-02 | 1.481 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.303089e-02 | 1.481 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.111137e-02 | 1.507 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.299867e-02 | 1.482 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.323756e-02 | 1.478 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.111137e-02 | 1.507 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.191332e-02 | 1.496 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.303089e-02 | 1.481 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.980659e-02 | 1.526 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.299867e-02 | 1.482 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.303089e-02 | 1.481 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.344346e-02 | 1.476 | 1 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.359232e-02 | 1.474 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.371869e-02 | 1.472 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.120938e-02 | 1.385 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.120938e-02 | 1.385 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.120938e-02 | 1.385 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.120938e-02 | 1.385 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.966796e-02 | 1.402 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.565134e-02 | 1.448 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.677257e-02 | 1.434 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.677257e-02 | 1.434 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.677257e-02 | 1.434 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.677257e-02 | 1.434 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.076429e-02 | 1.390 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.500844e-02 | 1.347 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.167161e-02 | 1.380 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.114401e-02 | 1.386 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.076429e-02 | 1.390 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.500844e-02 | 1.347 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.395195e-02 | 1.357 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.529869e-02 | 1.344 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.120938e-02 | 1.385 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.120938e-02 | 1.385 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.529513e-02 | 1.344 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.610497e-02 | 1.442 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.120938e-02 | 1.385 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.589159e-02 | 1.445 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.321740e-02 | 1.364 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.529869e-02 | 1.344 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.076429e-02 | 1.390 | 1 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.167161e-02 | 1.380 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.529869e-02 | 1.344 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.966796e-02 | 1.402 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.823328e-02 | 1.418 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 5.177119e-02 | 1.286 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 5.177119e-02 | 1.286 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 5.177119e-02 | 1.286 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.696447e-02 | 1.328 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.487148e-02 | 1.261 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.487148e-02 | 1.261 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.425993e-02 | 1.266 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.911640e-02 | 1.309 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.911640e-02 | 1.309 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.911640e-02 | 1.309 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.692893e-02 | 1.329 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.312143e-02 | 1.275 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.487148e-02 | 1.261 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.487148e-02 | 1.261 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.442954e-02 | 1.264 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.993929e-02 | 1.302 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.158309e-02 | 1.287 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.275497e-02 | 1.278 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.318384e-02 | 1.274 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.487148e-02 | 1.261 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.099769e-02 | 1.292 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.158309e-02 | 1.287 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.870088e-02 | 1.312 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 5.158309e-02 | 1.287 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.336712e-02 | 1.273 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.700222e-02 | 1.328 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.425993e-02 | 1.266 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.732917e-02 | 1.242 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.732917e-02 | 1.242 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.762771e-02 | 1.239 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.763275e-02 | 1.239 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.763275e-02 | 1.239 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.986824e-02 | 1.223 | 1 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.172598e-02 | 1.210 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.172598e-02 | 1.210 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 6.336887e-02 | 1.198 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 6.336887e-02 | 1.198 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 6.336887e-02 | 1.198 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.336887e-02 | 1.198 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.336887e-02 | 1.198 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.346880e-02 | 1.197 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.346880e-02 | 1.197 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 6.554198e-02 | 1.183 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.631687e-02 | 1.178 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.631687e-02 | 1.178 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.675894e-02 | 1.175 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 7.243376e-02 | 1.140 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.243376e-02 | 1.140 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.204100e-02 | 1.086 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.204100e-02 | 1.086 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.079681e-02 | 1.150 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.079681e-02 | 1.150 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.790951e-02 | 1.108 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.081924e-02 | 1.150 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.366708e-02 | 1.077 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.581568e-02 | 1.120 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.491302e-02 | 1.125 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.581568e-02 | 1.120 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.243376e-02 | 1.140 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.581568e-02 | 1.120 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.981289e-02 | 1.156 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.321690e-02 | 1.080 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 8.368850e-02 | 1.077 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.243376e-02 | 1.140 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 7.790951e-02 | 1.108 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 7.790951e-02 | 1.108 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.407516e-02 | 1.130 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.204100e-02 | 1.086 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 6.713066e-02 | 1.173 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.125078e-02 | 1.090 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.110171e-02 | 1.148 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 7.243376e-02 | 1.140 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.110171e-02 | 1.148 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.981289e-02 | 1.156 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.981289e-02 | 1.156 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.981289e-02 | 1.156 | 1 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.095668e-02 | 1.149 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.437760e-02 | 1.074 | 1 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.661280e-02 | 1.062 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 9.216359e-02 | 1.035 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 9.216359e-02 | 1.035 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.216442e-02 | 1.035 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.315296e-02 | 1.031 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.459976e-02 | 1.024 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 9.988153e-02 | 1.001 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 9.988153e-02 | 1.001 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.008651e-01 | 0.996 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.008651e-01 | 0.996 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.008651e-01 | 0.996 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.008651e-01 | 0.996 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.008651e-01 | 0.996 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.008651e-01 | 0.996 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.012653e-01 | 0.995 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.013421e-01 | 0.994 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.013421e-01 | 0.994 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.013421e-01 | 0.994 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.026744e-01 | 0.989 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.027071e-01 | 0.988 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.027731e-01 | 0.988 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.038281e-01 | 0.984 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.073774e-01 | 0.969 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.083174e-01 | 0.965 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.083174e-01 | 0.965 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.083174e-01 | 0.965 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.105987e-01 | 0.956 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.116684e-01 | 0.952 | 1 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.138402e-01 | 0.944 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.138402e-01 | 0.944 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.151117e-01 | 0.939 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.160553e-01 | 0.935 | 1 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.168548e-01 | 0.932 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.168548e-01 | 0.932 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.168548e-01 | 0.932 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.474200e-01 | 0.831 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 1.474200e-01 | 0.831 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.344845e-01 | 0.871 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.526572e-01 | 0.816 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.494823e-01 | 0.825 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.184187e-01 | 0.927 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.184187e-01 | 0.927 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.274365e-01 | 0.895 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.274365e-01 | 0.895 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.561023e-01 | 0.807 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.366855e-01 | 0.864 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 1.184187e-01 | 0.927 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.561023e-01 | 0.807 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.344845e-01 | 0.871 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.253346e-01 | 0.902 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.297066e-01 | 0.887 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.462915e-01 | 0.835 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.331400e-01 | 0.876 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.226845e-01 | 0.911 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.508012e-01 | 0.822 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.344776e-01 | 0.871 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 1.474200e-01 | 0.831 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.526572e-01 | 0.816 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 1.372256e-01 | 0.863 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.293063e-01 | 0.888 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.293063e-01 | 0.888 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.259659e-01 | 0.900 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 1.474200e-01 | 0.831 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.474200e-01 | 0.831 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.472890e-01 | 0.832 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.494823e-01 | 0.825 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.253346e-01 | 0.902 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.381102e-01 | 0.860 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.561023e-01 | 0.807 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.344845e-01 | 0.871 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.345457e-01 | 0.871 | 1 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.253346e-01 | 0.902 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.366855e-01 | 0.864 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.915671e-01 | 0.718 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.915671e-01 | 0.718 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 1.915671e-01 | 0.718 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 1.915671e-01 | 0.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.915671e-01 | 0.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.915671e-01 | 0.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.915671e-01 | 0.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.915671e-01 | 0.718 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 1.915671e-01 | 0.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.915671e-01 | 0.718 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.915671e-01 | 0.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.915671e-01 | 0.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.915671e-01 | 0.718 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 1.915671e-01 | 0.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.915671e-01 | 0.718 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 2.334308e-01 | 0.632 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.334308e-01 | 0.632 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.334308e-01 | 0.632 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.334308e-01 | 0.632 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.731290e-01 | 0.564 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.731290e-01 | 0.564 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.731290e-01 | 0.564 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.731290e-01 | 0.564 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.712696e-01 | 0.766 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.712696e-01 | 0.766 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.712696e-01 | 0.766 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 3.107736e-01 | 0.508 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.107736e-01 | 0.508 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.107736e-01 | 0.508 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.107736e-01 | 0.508 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.107736e-01 | 0.508 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 3.107736e-01 | 0.508 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.107736e-01 | 0.508 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 3.107736e-01 | 0.508 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 3.107736e-01 | 0.508 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.902277e-01 | 0.721 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.902277e-01 | 0.721 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.094460e-01 | 0.679 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.094460e-01 | 0.679 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.094460e-01 | 0.679 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 2.094460e-01 | 0.679 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.094460e-01 | 0.679 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.094460e-01 | 0.679 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.094460e-01 | 0.679 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.094460e-01 | 0.679 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.464708e-01 | 0.460 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.464708e-01 | 0.460 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.464708e-01 | 0.460 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.464708e-01 | 0.460 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.464708e-01 | 0.460 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.464708e-01 | 0.460 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.464708e-01 | 0.460 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 3.464708e-01 | 0.460 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.464708e-01 | 0.460 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 1.620741e-01 | 0.790 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 1.749701e-01 | 0.757 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.483597e-01 | 0.605 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.483597e-01 | 0.605 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.803211e-01 | 0.420 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.803211e-01 | 0.420 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.803211e-01 | 0.420 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.803211e-01 | 0.420 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 3.803211e-01 | 0.420 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.881401e-01 | 0.726 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.679213e-01 | 0.572 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.679213e-01 | 0.572 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.015544e-01 | 0.696 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 2.151838e-01 | 0.667 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.874743e-01 | 0.541 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.874743e-01 | 0.541 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 4.124201e-01 | 0.385 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.124201e-01 | 0.385 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.124201e-01 | 0.385 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 3.069672e-01 | 0.513 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.069672e-01 | 0.513 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 3.069672e-01 | 0.513 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.069672e-01 | 0.513 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.069672e-01 | 0.513 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.631652e-01 | 0.787 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 2.570829e-01 | 0.590 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.570829e-01 | 0.590 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.428582e-01 | 0.354 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.428582e-01 | 0.354 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 4.428582e-01 | 0.354 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.428582e-01 | 0.354 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.428582e-01 | 0.354 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.428582e-01 | 0.354 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.575089e-01 | 0.803 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.455931e-01 | 0.461 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.172451e-01 | 0.663 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 3.646482e-01 | 0.438 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.646482e-01 | 0.438 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.646482e-01 | 0.438 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.717213e-01 | 0.326 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.717213e-01 | 0.326 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.267594e-01 | 0.644 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.648969e-01 | 0.577 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.042136e-01 | 0.690 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.143381e-01 | 0.503 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 3.834867e-01 | 0.416 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.834867e-01 | 0.416 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.834867e-01 | 0.416 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.834867e-01 | 0.416 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.834867e-01 | 0.416 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.020799e-01 | 0.396 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.369234e-01 | 0.625 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.369234e-01 | 0.625 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.718375e-01 | 0.430 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.419250e-01 | 0.616 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.384336e-01 | 0.358 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.384336e-01 | 0.358 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.270489e-01 | 0.485 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.270489e-01 | 0.485 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 2.154533e-01 | 0.667 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.483219e-01 | 0.605 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.070580e-01 | 0.390 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.559675e-01 | 0.341 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.559675e-01 | 0.341 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.079159e-01 | 0.512 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.695556e-01 | 0.328 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.115263e-01 | 0.386 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.308279e-01 | 0.366 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.513381e-01 | 0.345 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 2.263385e-01 | 0.645 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.431394e-01 | 0.465 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.287421e-01 | 0.483 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.162328e-01 | 0.665 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.162328e-01 | 0.665 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.579144e-01 | 0.339 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.162328e-01 | 0.665 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.477812e-01 | 0.459 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.301587e-01 | 0.366 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.881106e-01 | 0.726 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 4.124201e-01 | 0.385 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.215342e-01 | 0.655 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.183348e-01 | 0.497 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.124201e-01 | 0.385 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.661503e-01 | 0.779 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.802515e-01 | 0.744 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.431394e-01 | 0.465 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.833321e-01 | 0.416 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.283696e-01 | 0.368 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.069672e-01 | 0.513 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.640149e-01 | 0.785 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.038032e-01 | 0.394 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.561928e-01 | 0.448 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.419250e-01 | 0.616 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.874743e-01 | 0.541 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.659277e-01 | 0.575 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 4.204029e-01 | 0.376 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 4.384336e-01 | 0.358 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.731290e-01 | 0.564 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.464708e-01 | 0.460 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.069672e-01 | 0.513 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 4.428582e-01 | 0.354 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.064515e-01 | 0.514 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.561533e-01 | 0.341 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.741281e-01 | 0.427 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.881401e-01 | 0.726 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.118606e-01 | 0.506 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 2.094460e-01 | 0.679 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.718375e-01 | 0.430 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.429752e-01 | 0.614 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.805622e-01 | 0.743 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.288467e-01 | 0.640 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.204029e-01 | 0.376 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.305985e-01 | 0.366 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.461275e-01 | 0.461 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.107736e-01 | 0.508 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 3.107736e-01 | 0.508 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.902277e-01 | 0.721 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.263539e-01 | 0.486 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.765297e-01 | 0.558 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.834867e-01 | 0.416 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.714240e-01 | 0.430 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.422351e-01 | 0.354 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.543329e-01 | 0.451 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.101642e-01 | 0.387 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.579144e-01 | 0.339 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.999481e-01 | 0.523 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.712696e-01 | 0.766 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.767243e-01 | 0.424 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.825674e-01 | 0.417 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.483597e-01 | 0.605 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.204029e-01 | 0.376 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.431314e-01 | 0.614 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.594995e-01 | 0.444 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.594995e-01 | 0.444 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.409989e-01 | 0.356 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.284138e-01 | 0.641 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.306209e-01 | 0.637 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.419285e-01 | 0.616 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.419285e-01 | 0.616 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.101642e-01 | 0.387 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.695556e-01 | 0.328 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.717213e-01 | 0.326 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.394086e-01 | 0.357 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.559675e-01 | 0.341 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.276463e-01 | 0.369 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.564778e-01 | 0.591 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.752852e-01 | 0.426 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.915671e-01 | 0.718 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.915671e-01 | 0.718 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.915671e-01 | 0.718 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.334308e-01 | 0.632 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.731290e-01 | 0.564 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.712696e-01 | 0.766 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.107736e-01 | 0.508 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.902277e-01 | 0.721 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.902277e-01 | 0.721 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.464708e-01 | 0.460 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.464708e-01 | 0.460 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 3.464708e-01 | 0.460 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.803211e-01 | 0.420 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 1.881401e-01 | 0.726 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.679213e-01 | 0.572 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.661503e-01 | 0.779 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.428582e-01 | 0.354 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.712973e-01 | 0.567 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.649454e-01 | 0.783 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.455931e-01 | 0.461 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.855936e-01 | 0.544 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.717213e-01 | 0.326 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.717213e-01 | 0.326 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.717213e-01 | 0.326 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.000248e-01 | 0.523 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.718375e-01 | 0.430 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.002896e-01 | 0.398 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.545532e-01 | 0.342 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.802515e-01 | 0.744 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.874743e-01 | 0.541 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.874743e-01 | 0.541 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.431394e-01 | 0.465 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.431394e-01 | 0.465 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.695556e-01 | 0.328 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.429752e-01 | 0.614 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.702233e-01 | 0.769 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.646482e-01 | 0.438 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.237641e-01 | 0.650 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.203522e-01 | 0.657 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.731290e-01 | 0.564 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 1.902277e-01 | 0.721 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.620741e-01 | 0.790 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.679213e-01 | 0.572 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.124201e-01 | 0.385 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.263539e-01 | 0.486 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.646482e-01 | 0.438 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.167293e-01 | 0.499 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.384336e-01 | 0.358 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.765297e-01 | 0.558 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.223148e-01 | 0.653 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.369234e-01 | 0.625 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.692746e-01 | 0.433 | 1 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.094460e-01 | 0.679 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.855936e-01 | 0.544 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.640070e-01 | 0.578 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.263581e-01 | 0.486 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.263581e-01 | 0.486 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.679213e-01 | 0.572 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.143381e-01 | 0.503 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.763792e-01 | 0.754 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.038281e-01 | 0.394 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.021858e-01 | 0.396 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.169985e-01 | 0.499 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.178474e-01 | 0.662 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.708095e-01 | 0.767 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.356451e-01 | 0.474 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.136370e-01 | 0.383 | 1 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.799558e-01 | 0.420 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.993551e-01 | 0.524 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.272930e-01 | 0.643 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.464708e-01 | 0.460 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.679213e-01 | 0.572 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 4.124201e-01 | 0.385 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.069672e-01 | 0.513 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.570829e-01 | 0.590 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.428582e-01 | 0.354 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.455931e-01 | 0.461 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.717213e-01 | 0.326 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.717213e-01 | 0.326 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.167293e-01 | 0.499 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.967776e-01 | 0.528 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.456923e-01 | 0.610 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.115263e-01 | 0.386 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.270489e-01 | 0.485 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.999481e-01 | 0.523 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.671465e-01 | 0.331 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.765297e-01 | 0.558 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.792234e-01 | 0.747 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.475694e-01 | 0.459 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.167779e-01 | 0.664 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.533585e-01 | 0.596 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.377986e-01 | 0.624 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.431394e-01 | 0.465 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.729050e-01 | 0.564 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.084301e-01 | 0.681 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.261186e-01 | 0.370 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.002896e-01 | 0.398 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.263539e-01 | 0.486 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 2.334308e-01 | 0.632 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.288467e-01 | 0.640 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 2.874743e-01 | 0.541 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 2.874743e-01 | 0.541 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 4.124201e-01 | 0.385 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.124201e-01 | 0.385 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.124201e-01 | 0.385 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.290000e-01 | 0.640 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.428582e-01 | 0.354 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.717213e-01 | 0.326 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.422351e-01 | 0.354 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.411053e-01 | 0.355 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.270489e-01 | 0.485 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.270489e-01 | 0.485 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.422767e-01 | 0.354 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 2.679213e-01 | 0.572 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.834867e-01 | 0.416 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.118606e-01 | 0.506 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.717780e-01 | 0.765 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.455931e-01 | 0.461 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.646482e-01 | 0.438 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.749701e-01 | 0.757 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.084301e-01 | 0.681 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.204029e-01 | 0.376 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.107736e-01 | 0.508 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.464708e-01 | 0.460 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.464708e-01 | 0.460 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.679213e-01 | 0.572 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.630131e-01 | 0.334 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.434971e-01 | 0.353 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.718375e-01 | 0.430 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.758421e-01 | 0.755 | 1 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.677494e-01 | 0.775 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 4.717213e-01 | 0.326 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.758421e-01 | 0.755 | 1 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.927023e-01 | 0.715 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.927023e-01 | 0.715 | 1 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.422767e-01 | 0.354 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.059939e-01 | 0.686 | 1 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.559867e-01 | 0.592 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.449311e-01 | 0.462 | 1 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.059939e-01 | 0.686 | 1 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.755124e-01 | 0.756 | 1 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.229490e-01 | 0.374 | 1 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.514001e-01 | 0.345 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.464708e-01 | 0.460 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.803211e-01 | 0.420 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.204029e-01 | 0.376 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.100957e-01 | 0.678 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.483597e-01 | 0.605 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.124201e-01 | 0.385 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.726703e-01 | 0.564 | 1 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.430694e-01 | 0.614 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.520416e-01 | 0.453 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.679213e-01 | 0.572 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.428582e-01 | 0.354 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.631652e-01 | 0.787 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.403269e-01 | 0.356 | 1 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.928358e-01 | 0.406 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.818738e-01 | 0.550 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.105576e-01 | 0.508 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.486944e-01 | 0.348 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 4.002896e-01 | 0.398 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.721387e-01 | 0.326 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.735457e-01 | 0.325 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.735457e-01 | 0.325 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.735457e-01 | 0.325 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.735457e-01 | 0.325 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 4.735457e-01 | 0.325 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.827810e-01 | 0.316 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.829888e-01 | 0.316 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.829888e-01 | 0.316 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.829888e-01 | 0.316 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.829888e-01 | 0.316 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.874635e-01 | 0.312 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.881854e-01 | 0.311 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.881854e-01 | 0.311 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.881854e-01 | 0.311 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.881854e-01 | 0.311 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.881854e-01 | 0.311 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.881854e-01 | 0.311 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.882004e-01 | 0.311 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 4.905974e-01 | 0.309 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.905974e-01 | 0.309 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.905974e-01 | 0.309 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.905974e-01 | 0.309 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 4.905974e-01 | 0.309 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 4.905974e-01 | 0.309 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.986715e-01 | 0.302 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.990908e-01 | 0.302 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.990908e-01 | 0.302 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.990908e-01 | 0.302 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.990908e-01 | 0.302 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.990908e-01 | 0.302 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 4.990908e-01 | 0.302 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 4.990908e-01 | 0.302 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 4.990908e-01 | 0.302 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.990908e-01 | 0.302 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.990908e-01 | 0.302 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 4.990908e-01 | 0.302 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.990908e-01 | 0.302 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.990908e-01 | 0.302 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.990908e-01 | 0.302 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.012657e-01 | 0.300 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.016397e-01 | 0.300 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.016397e-01 | 0.300 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.016397e-01 | 0.300 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 5.072968e-01 | 0.295 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.072968e-01 | 0.295 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.072968e-01 | 0.295 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.072968e-01 | 0.295 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.072968e-01 | 0.295 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.072968e-01 | 0.295 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.093534e-01 | 0.293 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.105571e-01 | 0.292 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.114915e-01 | 0.291 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.114915e-01 | 0.291 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.222681e-01 | 0.282 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.222681e-01 | 0.282 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.236348e-01 | 0.281 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.236348e-01 | 0.281 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.236348e-01 | 0.281 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 5.236348e-01 | 0.281 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.250439e-01 | 0.280 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.250439e-01 | 0.280 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.250439e-01 | 0.280 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 5.250439e-01 | 0.280 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.250439e-01 | 0.280 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.250439e-01 | 0.280 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 5.250439e-01 | 0.280 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.250439e-01 | 0.280 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.286920e-01 | 0.277 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.289433e-01 | 0.277 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.349946e-01 | 0.272 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.349946e-01 | 0.272 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.349946e-01 | 0.272 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.387198e-01 | 0.269 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.396040e-01 | 0.268 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.405477e-01 | 0.267 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.432481e-01 | 0.265 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.475265e-01 | 0.262 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.496538e-01 | 0.260 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.496538e-01 | 0.260 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.496538e-01 | 0.260 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 5.496538e-01 | 0.260 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.496538e-01 | 0.260 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.496538e-01 | 0.260 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 5.496538e-01 | 0.260 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 5.496538e-01 | 0.260 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 5.496538e-01 | 0.260 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.551987e-01 | 0.256 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.551987e-01 | 0.256 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.551987e-01 | 0.256 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.559860e-01 | 0.255 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.559860e-01 | 0.255 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.598582e-01 | 0.252 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.644052e-01 | 0.248 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.684855e-01 | 0.245 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.704149e-01 | 0.244 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.704149e-01 | 0.244 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.713322e-01 | 0.243 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.719845e-01 | 0.243 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.729473e-01 | 0.242 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.729899e-01 | 0.242 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.729899e-01 | 0.242 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.729899e-01 | 0.242 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.729899e-01 | 0.242 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.729899e-01 | 0.242 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.747796e-01 | 0.240 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.779821e-01 | 0.238 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.813071e-01 | 0.236 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.813071e-01 | 0.236 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.813071e-01 | 0.236 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 5.839013e-01 | 0.234 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.850131e-01 | 0.233 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.852499e-01 | 0.233 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.852499e-01 | 0.233 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.922768e-01 | 0.227 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.951022e-01 | 0.225 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.951181e-01 | 0.225 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.951181e-01 | 0.225 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.951181e-01 | 0.225 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.951181e-01 | 0.225 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 5.951181e-01 | 0.225 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.951181e-01 | 0.225 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.951181e-01 | 0.225 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.951181e-01 | 0.225 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.951181e-01 | 0.225 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.951181e-01 | 0.225 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.951181e-01 | 0.225 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.956046e-01 | 0.225 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.997024e-01 | 0.222 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.050441e-01 | 0.218 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.050441e-01 | 0.218 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.050441e-01 | 0.218 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.137365e-01 | 0.212 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.137721e-01 | 0.212 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.137721e-01 | 0.212 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.137721e-01 | 0.212 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.137721e-01 | 0.212 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 6.137721e-01 | 0.212 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.143356e-01 | 0.212 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.147538e-01 | 0.211 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.148360e-01 | 0.211 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.161009e-01 | 0.210 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.161009e-01 | 0.210 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.161009e-01 | 0.210 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.183590e-01 | 0.209 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.183590e-01 | 0.209 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.191744e-01 | 0.208 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.274600e-01 | 0.202 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.274600e-01 | 0.202 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 6.274600e-01 | 0.202 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.274600e-01 | 0.202 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.288109e-01 | 0.201 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.294054e-01 | 0.201 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.294054e-01 | 0.201 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.309338e-01 | 0.200 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.359975e-01 | 0.197 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.359975e-01 | 0.197 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.359975e-01 | 0.197 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.359975e-01 | 0.197 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.359975e-01 | 0.197 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.359975e-01 | 0.197 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.359975e-01 | 0.197 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.359975e-01 | 0.197 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.359975e-01 | 0.197 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.359975e-01 | 0.197 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.359975e-01 | 0.197 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.359975e-01 | 0.197 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.359975e-01 | 0.197 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.359975e-01 | 0.197 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.407678e-01 | 0.193 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.407678e-01 | 0.193 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 6.407678e-01 | 0.193 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.407678e-01 | 0.193 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.407678e-01 | 0.193 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.432904e-01 | 0.192 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.476575e-01 | 0.189 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.500736e-01 | 0.187 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.506741e-01 | 0.187 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.508282e-01 | 0.187 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.524621e-01 | 0.185 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.525422e-01 | 0.185 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 6.536981e-01 | 0.185 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.536981e-01 | 0.185 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.536981e-01 | 0.185 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.548640e-01 | 0.184 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.548640e-01 | 0.184 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.548640e-01 | 0.184 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.548640e-01 | 0.184 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.548640e-01 | 0.184 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.548640e-01 | 0.184 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.548640e-01 | 0.184 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.548640e-01 | 0.184 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.599816e-01 | 0.180 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.612029e-01 | 0.180 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.612029e-01 | 0.180 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.662543e-01 | 0.176 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.662543e-01 | 0.176 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.662543e-01 | 0.176 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.668259e-01 | 0.176 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.691066e-01 | 0.175 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.703279e-01 | 0.174 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.703279e-01 | 0.174 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.718301e-01 | 0.173 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.727537e-01 | 0.172 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.727537e-01 | 0.172 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 6.727537e-01 | 0.172 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.727537e-01 | 0.172 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 6.727537e-01 | 0.172 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.727537e-01 | 0.172 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.737766e-01 | 0.171 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.745598e-01 | 0.171 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.784405e-01 | 0.168 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 6.784405e-01 | 0.168 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 6.784405e-01 | 0.168 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.790203e-01 | 0.168 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.796399e-01 | 0.168 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.821668e-01 | 0.166 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 6.897172e-01 | 0.161 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.897172e-01 | 0.161 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.897172e-01 | 0.161 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 6.897172e-01 | 0.161 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.897172e-01 | 0.161 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.897172e-01 | 0.161 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.897172e-01 | 0.161 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.897172e-01 | 0.161 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.902612e-01 | 0.161 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.909773e-01 | 0.161 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.909773e-01 | 0.161 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.956630e-01 | 0.158 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.956630e-01 | 0.158 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.017215e-01 | 0.154 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.058008e-01 | 0.151 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.058023e-01 | 0.151 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.058023e-01 | 0.151 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.058023e-01 | 0.151 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.058023e-01 | 0.151 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.058023e-01 | 0.151 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.058023e-01 | 0.151 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.058023e-01 | 0.151 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.058023e-01 | 0.151 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.058023e-01 | 0.151 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.097072e-01 | 0.149 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 7.097072e-01 | 0.149 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.100696e-01 | 0.149 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.121761e-01 | 0.147 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.128271e-01 | 0.147 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.128271e-01 | 0.147 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.128271e-01 | 0.147 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.187395e-01 | 0.143 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.187395e-01 | 0.143 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.210545e-01 | 0.142 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 7.210545e-01 | 0.142 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 7.210545e-01 | 0.142 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.210545e-01 | 0.142 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.210545e-01 | 0.142 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.210545e-01 | 0.142 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 7.210545e-01 | 0.142 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.210545e-01 | 0.142 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.210545e-01 | 0.142 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 7.210545e-01 | 0.142 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.210545e-01 | 0.142 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.223070e-01 | 0.141 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.223503e-01 | 0.141 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.223503e-01 | 0.141 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.275520e-01 | 0.138 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.277862e-01 | 0.138 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.307783e-01 | 0.136 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.339983e-01 | 0.134 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.339983e-01 | 0.134 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.339983e-01 | 0.134 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 7.339983e-01 | 0.134 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.341882e-01 | 0.134 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.355168e-01 | 0.133 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.355168e-01 | 0.133 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.355168e-01 | 0.133 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.355168e-01 | 0.133 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.355168e-01 | 0.133 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.355168e-01 | 0.133 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.355168e-01 | 0.133 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 7.355168e-01 | 0.133 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.355168e-01 | 0.133 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.357069e-01 | 0.133 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 7.440768e-01 | 0.128 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 7.440768e-01 | 0.128 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.440768e-01 | 0.128 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.440768e-01 | 0.128 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 7.440768e-01 | 0.128 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.440768e-01 | 0.128 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.442500e-01 | 0.128 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.457120e-01 | 0.127 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.492301e-01 | 0.125 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 7.492301e-01 | 0.125 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.492301e-01 | 0.125 | 1 | 1 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.492301e-01 | 0.125 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.492301e-01 | 0.125 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.492301e-01 | 0.125 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.492301e-01 | 0.125 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.492301e-01 | 0.125 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 7.492301e-01 | 0.125 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.492301e-01 | 0.125 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.538261e-01 | 0.123 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.560448e-01 | 0.121 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 7.606451e-01 | 0.119 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.622332e-01 | 0.118 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.622332e-01 | 0.118 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.622332e-01 | 0.118 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.622332e-01 | 0.118 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.622332e-01 | 0.118 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.632535e-01 | 0.117 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.632535e-01 | 0.117 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.635149e-01 | 0.117 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 7.683909e-01 | 0.114 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 7.700632e-01 | 0.113 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.708011e-01 | 0.113 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.721858e-01 | 0.112 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.723659e-01 | 0.112 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.723659e-01 | 0.112 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.723659e-01 | 0.112 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.723659e-01 | 0.112 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.745628e-01 | 0.111 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.745628e-01 | 0.111 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.745628e-01 | 0.111 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.745628e-01 | 0.111 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.745628e-01 | 0.111 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.745628e-01 | 0.111 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.745628e-01 | 0.111 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.745628e-01 | 0.111 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.745628e-01 | 0.111 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.811707e-01 | 0.107 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.811707e-01 | 0.107 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.811707e-01 | 0.107 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.811707e-01 | 0.107 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.811707e-01 | 0.107 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.811707e-01 | 0.107 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.811707e-01 | 0.107 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.811707e-01 | 0.107 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.832686e-01 | 0.106 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.855642e-01 | 0.105 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.862538e-01 | 0.104 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.862538e-01 | 0.104 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 7.862538e-01 | 0.104 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.862538e-01 | 0.104 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 7.862538e-01 | 0.104 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.862538e-01 | 0.104 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.862538e-01 | 0.104 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.862538e-01 | 0.104 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.874681e-01 | 0.104 | 1 | 1 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.896753e-01 | 0.103 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.902178e-01 | 0.102 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.931679e-01 | 0.101 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.973391e-01 | 0.098 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.973391e-01 | 0.098 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.973391e-01 | 0.098 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.973391e-01 | 0.098 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.973391e-01 | 0.098 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.973391e-01 | 0.098 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.973478e-01 | 0.098 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.973478e-01 | 0.098 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.978872e-01 | 0.098 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 7.978872e-01 | 0.098 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.021933e-01 | 0.096 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.040960e-01 | 0.095 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.040960e-01 | 0.095 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.058137e-01 | 0.094 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.078502e-01 | 0.093 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.078502e-01 | 0.093 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.078502e-01 | 0.093 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.078502e-01 | 0.093 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.078502e-01 | 0.093 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 8.078502e-01 | 0.093 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 8.078502e-01 | 0.093 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 8.078502e-01 | 0.093 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 8.078502e-01 | 0.093 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.164816e-01 | 0.088 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.170259e-01 | 0.088 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.170259e-01 | 0.088 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.178167e-01 | 0.087 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.178167e-01 | 0.087 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.178167e-01 | 0.087 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 8.178167e-01 | 0.087 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.178167e-01 | 0.087 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.178167e-01 | 0.087 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 8.208409e-01 | 0.086 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.208409e-01 | 0.086 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.208906e-01 | 0.086 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.219591e-01 | 0.085 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.272668e-01 | 0.082 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.272668e-01 | 0.082 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.272668e-01 | 0.082 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.272668e-01 | 0.082 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.272668e-01 | 0.082 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.279565e-01 | 0.082 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.279565e-01 | 0.082 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.279565e-01 | 0.082 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.292237e-01 | 0.081 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.348165e-01 | 0.078 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.348165e-01 | 0.078 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.350568e-01 | 0.078 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.362273e-01 | 0.078 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.362273e-01 | 0.078 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.362273e-01 | 0.078 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.362273e-01 | 0.078 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.362273e-01 | 0.078 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.362273e-01 | 0.078 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.372856e-01 | 0.077 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.414285e-01 | 0.075 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.414285e-01 | 0.075 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.447235e-01 | 0.073 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 8.447235e-01 | 0.073 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.447235e-01 | 0.073 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.447235e-01 | 0.073 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.447235e-01 | 0.073 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.455541e-01 | 0.073 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.462096e-01 | 0.073 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.477996e-01 | 0.072 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.487224e-01 | 0.071 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.523933e-01 | 0.069 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.527794e-01 | 0.069 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.527794e-01 | 0.069 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.527794e-01 | 0.069 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.527794e-01 | 0.069 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.539370e-01 | 0.069 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.539370e-01 | 0.069 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.595496e-01 | 0.066 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.598478e-01 | 0.066 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.604178e-01 | 0.065 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.604178e-01 | 0.065 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.604178e-01 | 0.065 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.604178e-01 | 0.065 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.604178e-01 | 0.065 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.638070e-01 | 0.064 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.654307e-01 | 0.063 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.655390e-01 | 0.063 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.665622e-01 | 0.062 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.674141e-01 | 0.062 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.676603e-01 | 0.062 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.676603e-01 | 0.062 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.676603e-01 | 0.062 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.676603e-01 | 0.062 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.709819e-01 | 0.060 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.710174e-01 | 0.060 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.710174e-01 | 0.060 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.710174e-01 | 0.060 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.712647e-01 | 0.060 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.724486e-01 | 0.059 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.724486e-01 | 0.059 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.745275e-01 | 0.058 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.745275e-01 | 0.058 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.745275e-01 | 0.058 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.745275e-01 | 0.058 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.762899e-01 | 0.057 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.762899e-01 | 0.057 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.765153e-01 | 0.057 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.775077e-01 | 0.057 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.810387e-01 | 0.055 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.810387e-01 | 0.055 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.810387e-01 | 0.055 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.810387e-01 | 0.055 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.810387e-01 | 0.055 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.813629e-01 | 0.055 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 8.813629e-01 | 0.055 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.813629e-01 | 0.055 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.813629e-01 | 0.055 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 8.813629e-01 | 0.055 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.857759e-01 | 0.053 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.862431e-01 | 0.052 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.862431e-01 | 0.052 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.872124e-01 | 0.052 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.872124e-01 | 0.052 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.872124e-01 | 0.052 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.872124e-01 | 0.052 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.872124e-01 | 0.052 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.872124e-01 | 0.052 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.886395e-01 | 0.051 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.930661e-01 | 0.049 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.930661e-01 | 0.049 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.930661e-01 | 0.049 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.930661e-01 | 0.049 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.930661e-01 | 0.049 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 8.930661e-01 | 0.049 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.968077e-01 | 0.047 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.986163e-01 | 0.046 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.986163e-01 | 0.046 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.986163e-01 | 0.046 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.986163e-01 | 0.046 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.986163e-01 | 0.046 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.986163e-01 | 0.046 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.986163e-01 | 0.046 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 8.997888e-01 | 0.046 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.038787e-01 | 0.044 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.038787e-01 | 0.044 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.038787e-01 | 0.044 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.038787e-01 | 0.044 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.038787e-01 | 0.044 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.038787e-01 | 0.044 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.051856e-01 | 0.043 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.073915e-01 | 0.042 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.079674e-01 | 0.042 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.079674e-01 | 0.042 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.082033e-01 | 0.042 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.088683e-01 | 0.041 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.088683e-01 | 0.041 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.088683e-01 | 0.041 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.088683e-01 | 0.041 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.088683e-01 | 0.041 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.088683e-01 | 0.041 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.107803e-01 | 0.041 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.107803e-01 | 0.041 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.110360e-01 | 0.040 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.113631e-01 | 0.040 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.118185e-01 | 0.040 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.135992e-01 | 0.039 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.135992e-01 | 0.039 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.135992e-01 | 0.039 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.135992e-01 | 0.039 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.140561e-01 | 0.039 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.172221e-01 | 0.038 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.180847e-01 | 0.037 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.180847e-01 | 0.037 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.180847e-01 | 0.037 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 9.180847e-01 | 0.037 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.180847e-01 | 0.037 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.186666e-01 | 0.037 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.220502e-01 | 0.035 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.223377e-01 | 0.035 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.223377e-01 | 0.035 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.223377e-01 | 0.035 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.223377e-01 | 0.035 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.223377e-01 | 0.035 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.224840e-01 | 0.035 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.224840e-01 | 0.035 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.255107e-01 | 0.034 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.263700e-01 | 0.033 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 9.263700e-01 | 0.033 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.263700e-01 | 0.033 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.263700e-01 | 0.033 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.263700e-01 | 0.033 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.263700e-01 | 0.033 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.275170e-01 | 0.033 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.288499e-01 | 0.032 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.288499e-01 | 0.032 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.301933e-01 | 0.031 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.315126e-01 | 0.031 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.316086e-01 | 0.031 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.319257e-01 | 0.031 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.319257e-01 | 0.031 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.338182e-01 | 0.030 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.338182e-01 | 0.030 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.338182e-01 | 0.030 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.348235e-01 | 0.029 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.349019e-01 | 0.029 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.372551e-01 | 0.028 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.372551e-01 | 0.028 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.372551e-01 | 0.028 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.372551e-01 | 0.028 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.372551e-01 | 0.028 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.376041e-01 | 0.028 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.405137e-01 | 0.027 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.405137e-01 | 0.027 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.405137e-01 | 0.027 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.405137e-01 | 0.027 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.405137e-01 | 0.027 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.405137e-01 | 0.027 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.428313e-01 | 0.026 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.434674e-01 | 0.025 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.435007e-01 | 0.025 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.436033e-01 | 0.025 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.436033e-01 | 0.025 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.448879e-01 | 0.025 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.465326e-01 | 0.024 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.465326e-01 | 0.024 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.471447e-01 | 0.024 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.471447e-01 | 0.024 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.493099e-01 | 0.023 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.509617e-01 | 0.022 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.516567e-01 | 0.022 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.519431e-01 | 0.021 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.519431e-01 | 0.021 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.526870e-01 | 0.021 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.535168e-01 | 0.021 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.535168e-01 | 0.021 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.543564e-01 | 0.020 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.544397e-01 | 0.020 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.553098e-01 | 0.020 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.555872e-01 | 0.020 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.568067e-01 | 0.019 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.568067e-01 | 0.019 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.568067e-01 | 0.019 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.568067e-01 | 0.019 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.568067e-01 | 0.019 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.570380e-01 | 0.019 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 9.590509e-01 | 0.018 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.590509e-01 | 0.018 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.590509e-01 | 0.018 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.598592e-01 | 0.018 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.603082e-01 | 0.018 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.603082e-01 | 0.018 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.611786e-01 | 0.017 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.631958e-01 | 0.016 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.631958e-01 | 0.016 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.632866e-01 | 0.016 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.645828e-01 | 0.016 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.648932e-01 | 0.016 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.651084e-01 | 0.015 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.651084e-01 | 0.015 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.664320e-01 | 0.015 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.669217e-01 | 0.015 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.669217e-01 | 0.015 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.671122e-01 | 0.015 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.671122e-01 | 0.015 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.671122e-01 | 0.015 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.679059e-01 | 0.014 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.687707e-01 | 0.014 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.687707e-01 | 0.014 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.693173e-01 | 0.014 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.700037e-01 | 0.013 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.702708e-01 | 0.013 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.702708e-01 | 0.013 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.706689e-01 | 0.013 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.713566e-01 | 0.013 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.718160e-01 | 0.012 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.719630e-01 | 0.012 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.732811e-01 | 0.012 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.732811e-01 | 0.012 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.741291e-01 | 0.011 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.755230e-01 | 0.011 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.758950e-01 | 0.011 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.766095e-01 | 0.010 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.766095e-01 | 0.010 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.766095e-01 | 0.010 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.768798e-01 | 0.010 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.772354e-01 | 0.010 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.776393e-01 | 0.010 | 1 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.776492e-01 | 0.010 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.784190e-01 | 0.009 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.784190e-01 | 0.009 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.784190e-01 | 0.009 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.797836e-01 | 0.009 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.805379e-01 | 0.009 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.806051e-01 | 0.009 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.816137e-01 | 0.008 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.822119e-01 | 0.008 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.825699e-01 | 0.008 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.837717e-01 | 0.007 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.839273e-01 | 0.007 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.839273e-01 | 0.007 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.843359e-01 | 0.007 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.843359e-01 | 0.007 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.843359e-01 | 0.007 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.851507e-01 | 0.006 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.851507e-01 | 0.006 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.862112e-01 | 0.006 | 1 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.866555e-01 | 0.006 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.876947e-01 | 0.005 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.878862e-01 | 0.005 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.887840e-01 | 0.005 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.888661e-01 | 0.005 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.897842e-01 | 0.004 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.897842e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.897842e-01 | 0.004 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.897842e-01 | 0.004 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.903159e-01 | 0.004 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.912977e-01 | 0.004 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.919049e-01 | 0.004 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.921801e-01 | 0.003 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.925872e-01 | 0.003 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.933759e-01 | 0.003 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.949018e-01 | 0.002 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.949018e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.960983e-01 | 0.002 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.965436e-01 | 0.002 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.966769e-01 | 0.001 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.966769e-01 | 0.001 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.969436e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.973173e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.974515e-01 | 0.001 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.975477e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.980579e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.982606e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.985375e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.986752e-01 | 0.001 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.987155e-01 | 0.001 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.987155e-01 | 0.001 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.988512e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.989055e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.992197e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.992583e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.993584e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.993685e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.994623e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.995422e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.996064e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.996064e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.996920e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.998169e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.998258e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.998569e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.998589e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998738e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.998783e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999011e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999431e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999714e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999768e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999779e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999808e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999827e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999833e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999846e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999850e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999882e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999931e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999944e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999973e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999978e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999990e-01 | 0.000 | 1 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999997e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999998e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999998e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 6.217249e-15 | 14.206 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.589662e-13 | 12.338 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.779399e-12 | 11.321 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.850418e-10 | 9.414 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.344963e-09 | 8.871 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.554289e-09 | 8.342 | 0 | 0 |
| M Phase | R-HSA-68886 | 8.725780e-09 | 8.059 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.139488e-08 | 7.943 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.561443e-08 | 7.255 | 1 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.254324e-07 | 6.902 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.665294e-07 | 6.436 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.622573e-07 | 6.250 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.241043e-07 | 6.281 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.654447e-07 | 6.248 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.397456e-07 | 6.194 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.410615e-07 | 6.130 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.123421e-07 | 6.090 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.123421e-07 | 6.090 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 9.011875e-07 | 6.045 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.702081e-07 | 6.060 | 1 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 9.011875e-07 | 6.045 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.036703e-06 | 5.984 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.229166e-06 | 5.910 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.634904e-06 | 5.787 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.657013e-06 | 5.781 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.759420e-06 | 5.755 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.874378e-06 | 5.727 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.968819e-06 | 5.706 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.310210e-06 | 5.636 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.280244e-06 | 5.642 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.609239e-06 | 5.443 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.753633e-06 | 5.426 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.134089e-06 | 5.384 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.811426e-06 | 5.318 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.811426e-06 | 5.318 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.947443e-06 | 5.226 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.373411e-06 | 5.196 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.745525e-06 | 5.111 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.745525e-06 | 5.111 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.533760e-06 | 5.069 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.570108e-06 | 5.019 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.036754e-05 | 4.984 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.103689e-05 | 4.957 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.074445e-05 | 4.969 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.366865e-05 | 4.864 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.889247e-05 | 4.724 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.982270e-05 | 4.703 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.026969e-05 | 4.693 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.064697e-05 | 4.514 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.064697e-05 | 4.514 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.966534e-05 | 4.528 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.612636e-05 | 4.442 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.579986e-05 | 4.446 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.821181e-05 | 4.418 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.048966e-05 | 4.393 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.048966e-05 | 4.393 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.894814e-05 | 4.410 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.569777e-05 | 4.340 | 1 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.773939e-05 | 4.321 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.107033e-05 | 4.214 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.991287e-05 | 4.155 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.685683e-05 | 4.114 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.842460e-05 | 4.106 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 8.937047e-05 | 4.049 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 9.583333e-05 | 4.018 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.583333e-05 | 4.018 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.033424e-04 | 3.986 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.077906e-04 | 3.967 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.263980e-04 | 3.898 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.261603e-04 | 3.899 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.462532e-04 | 3.835 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.462532e-04 | 3.835 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.554078e-04 | 3.809 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.616843e-04 | 3.791 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.661283e-04 | 3.780 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.835995e-04 | 3.736 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.758031e-04 | 3.755 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.104658e-04 | 3.677 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.215710e-04 | 3.654 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.258761e-04 | 3.646 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.643208e-04 | 3.578 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.509699e-04 | 3.600 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.694289e-04 | 3.570 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.981235e-04 | 3.526 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.981235e-04 | 3.526 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.485016e-04 | 3.458 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.485016e-04 | 3.458 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.434112e-04 | 3.464 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.460994e-04 | 3.461 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.521777e-04 | 3.453 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.521777e-04 | 3.453 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.698300e-04 | 3.432 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.264048e-04 | 3.370 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.751480e-04 | 3.323 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.800609e-04 | 3.319 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.832125e-04 | 3.316 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.888683e-04 | 3.311 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.283190e-04 | 3.277 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.368134e-04 | 3.270 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.865219e-04 | 3.232 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.344111e-04 | 3.198 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.489725e-04 | 3.188 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.489725e-04 | 3.188 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.536657e-04 | 3.185 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 7.576306e-04 | 3.121 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 7.576306e-04 | 3.121 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.527886e-04 | 3.069 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.527886e-04 | 3.069 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.527886e-04 | 3.069 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.527886e-04 | 3.069 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.810779e-04 | 3.055 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 9.402607e-04 | 3.027 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.608808e-04 | 3.017 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 9.608808e-04 | 3.017 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.712920e-04 | 3.013 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.020393e-03 | 2.991 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.929091e-04 | 3.003 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.069025e-03 | 2.971 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.123124e-03 | 2.950 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.123124e-03 | 2.950 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.160613e-03 | 2.935 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.280647e-03 | 2.893 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.284887e-03 | 2.891 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.380628e-03 | 2.860 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.412271e-03 | 2.850 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.510358e-03 | 2.821 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.575752e-03 | 2.803 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.639393e-03 | 2.785 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.808295e-03 | 2.743 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.820335e-03 | 2.740 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.845303e-03 | 2.734 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.976160e-03 | 2.704 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.983671e-03 | 2.703 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.078530e-03 | 2.682 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.156628e-03 | 2.666 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.386684e-03 | 2.622 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.586979e-03 | 2.587 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.761244e-03 | 2.559 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.806472e-03 | 2.552 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.053459e-03 | 2.515 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.957247e-03 | 2.529 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.145551e-03 | 2.502 | 1 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.533306e-03 | 2.452 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.559167e-03 | 2.449 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.964395e-03 | 2.402 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.087118e-03 | 2.389 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.087118e-03 | 2.389 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.087118e-03 | 2.389 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.192338e-03 | 2.378 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.252509e-03 | 2.371 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 4.615571e-03 | 2.336 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 4.615571e-03 | 2.336 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.829683e-03 | 2.316 | 1 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.353044e-03 | 2.361 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.442943e-03 | 2.352 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.849894e-03 | 2.233 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.878994e-03 | 2.231 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.949079e-03 | 2.226 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.953574e-03 | 2.225 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.038029e-03 | 2.219 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.095641e-03 | 2.215 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.127878e-03 | 2.147 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.396172e-03 | 2.131 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.804089e-03 | 2.167 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 6.591295e-03 | 2.181 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.927076e-03 | 2.159 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.666412e-03 | 2.115 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.980995e-03 | 2.098 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 7.984551e-03 | 2.098 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.102396e-03 | 2.091 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 8.104971e-03 | 2.091 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.197722e-03 | 2.086 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.254886e-03 | 2.083 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.335634e-03 | 2.079 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.105101e-03 | 2.041 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.662740e-03 | 2.015 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.683829e-03 | 2.014 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.756705e-03 | 2.011 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.898484e-03 | 2.004 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.030606e-02 | 1.987 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.030606e-02 | 1.987 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.047413e-02 | 1.980 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.061819e-02 | 1.974 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.095758e-02 | 1.960 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.236512e-02 | 1.908 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.241425e-02 | 1.906 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.236512e-02 | 1.908 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.089822e-02 | 1.963 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.133434e-02 | 1.946 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.221352e-02 | 1.913 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.112096e-02 | 1.954 | 1 | 0 |
| S Phase | R-HSA-69242 | 1.264681e-02 | 1.898 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.264681e-02 | 1.898 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.310234e-02 | 1.883 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.315628e-02 | 1.881 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.315628e-02 | 1.881 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.360786e-02 | 1.866 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.389096e-02 | 1.857 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.405630e-02 | 1.852 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.420111e-02 | 1.848 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.505729e-02 | 1.822 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.572994e-02 | 1.803 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.577904e-02 | 1.802 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.577904e-02 | 1.802 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.603759e-02 | 1.795 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.603759e-02 | 1.795 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.615957e-02 | 1.792 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.667119e-02 | 1.778 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.688298e-02 | 1.773 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.814069e-02 | 1.741 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.906276e-02 | 1.720 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.906276e-02 | 1.720 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.669591e-02 | 1.777 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.745090e-02 | 1.758 | 1 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.669591e-02 | 1.777 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.814069e-02 | 1.741 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.943529e-02 | 1.711 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.946429e-02 | 1.711 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.946429e-02 | 1.711 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.946429e-02 | 1.711 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.946429e-02 | 1.711 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.946429e-02 | 1.711 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.021441e-02 | 1.694 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.046813e-02 | 1.689 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.061168e-02 | 1.686 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.066610e-02 | 1.685 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.247447e-02 | 1.648 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.247447e-02 | 1.648 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.247447e-02 | 1.648 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.247447e-02 | 1.648 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.272401e-02 | 1.644 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.272401e-02 | 1.644 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.292701e-02 | 1.640 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.292701e-02 | 1.640 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.367922e-02 | 1.626 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.372616e-02 | 1.625 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.372616e-02 | 1.625 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.464772e-02 | 1.608 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.511267e-02 | 1.600 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.620392e-02 | 1.582 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.628477e-02 | 1.580 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.667736e-02 | 1.574 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.667736e-02 | 1.574 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.669705e-02 | 1.574 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.734960e-02 | 1.563 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.769991e-02 | 1.558 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.910603e-02 | 1.536 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.910603e-02 | 1.536 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.023915e-02 | 1.519 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.049508e-02 | 1.516 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.052482e-02 | 1.515 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.064746e-02 | 1.514 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.067944e-02 | 1.513 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.067944e-02 | 1.513 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.132189e-02 | 1.504 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.763209e-02 | 1.424 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.221871e-02 | 1.492 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.457042e-02 | 1.461 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.577902e-02 | 1.446 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.207889e-02 | 1.494 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.924781e-02 | 1.406 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.924781e-02 | 1.406 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.924781e-02 | 1.406 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.924781e-02 | 1.406 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.935517e-02 | 1.405 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.937942e-02 | 1.405 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.969302e-02 | 1.401 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.001093e-02 | 1.398 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.008189e-02 | 1.397 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.008189e-02 | 1.397 | 1 | 1 |
| Unwinding of DNA | R-HSA-176974 | 4.008189e-02 | 1.397 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.040790e-02 | 1.394 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.040790e-02 | 1.394 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.087912e-02 | 1.388 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.087912e-02 | 1.388 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.106741e-02 | 1.387 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.134541e-02 | 1.384 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.191372e-02 | 1.378 | 1 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.293350e-02 | 1.367 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.338643e-02 | 1.363 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.437158e-02 | 1.353 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.459499e-02 | 1.351 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.605183e-02 | 1.337 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.747418e-02 | 1.324 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.950768e-02 | 1.305 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.958828e-02 | 1.305 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.053195e-02 | 1.296 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.094486e-02 | 1.293 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.094486e-02 | 1.293 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.142838e-02 | 1.289 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.231111e-02 | 1.281 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 5.231111e-02 | 1.281 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.350346e-02 | 1.272 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.350346e-02 | 1.272 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.382480e-02 | 1.269 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.430328e-02 | 1.265 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.787950e-02 | 1.168 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 6.787950e-02 | 1.168 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.787950e-02 | 1.168 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.787950e-02 | 1.168 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.787950e-02 | 1.168 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.787950e-02 | 1.168 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.787950e-02 | 1.168 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 6.787950e-02 | 1.168 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.787950e-02 | 1.168 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.787950e-02 | 1.168 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.787950e-02 | 1.168 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.787950e-02 | 1.168 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.787950e-02 | 1.168 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.364526e-02 | 1.196 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.882602e-02 | 1.230 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.668623e-02 | 1.247 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.952750e-02 | 1.225 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.068528e-02 | 1.217 | 1 | 1 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.447742e-02 | 1.191 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.928455e-02 | 1.227 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.532763e-02 | 1.185 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.294483e-02 | 1.201 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.003866e-02 | 1.155 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 7.036450e-02 | 1.153 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.159699e-02 | 1.145 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 7.170086e-02 | 1.144 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 7.170086e-02 | 1.144 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.398961e-02 | 1.131 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.448590e-02 | 1.128 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.479070e-02 | 1.126 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.479070e-02 | 1.126 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.486070e-02 | 1.126 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.726502e-02 | 1.112 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.726502e-02 | 1.112 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.726502e-02 | 1.112 | 1 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.798616e-02 | 1.108 | 1 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.816131e-02 | 1.107 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.005218e-02 | 1.097 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.053987e-02 | 1.094 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.053987e-02 | 1.094 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.217428e-02 | 1.085 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 8.274343e-02 | 1.082 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.277405e-02 | 1.082 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.004153e-01 | 0.998 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.004153e-01 | 0.998 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.004153e-01 | 0.998 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 9.912906e-02 | 1.004 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 9.912906e-02 | 1.004 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 9.125288e-02 | 1.040 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 9.125288e-02 | 1.040 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 9.206342e-02 | 1.036 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.084330e-01 | 0.965 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.084330e-01 | 0.965 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.084330e-01 | 0.965 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.000155e-01 | 1.000 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.000155e-01 | 1.000 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.000155e-01 | 1.000 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.140331e-01 | 0.943 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.082338e-02 | 1.042 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.023384e-01 | 0.990 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.050204e-02 | 1.043 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 9.206342e-02 | 1.036 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 9.155073e-02 | 1.038 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 9.206342e-02 | 1.036 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.050204e-02 | 1.043 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.000155e-01 | 1.000 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.126393e-01 | 0.948 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.000155e-01 | 1.000 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.155073e-02 | 1.038 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.084330e-01 | 0.965 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 9.125288e-02 | 1.040 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.127422e-01 | 0.948 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.153537e-01 | 0.938 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.787509e-02 | 1.056 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.127422e-01 | 0.948 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.127422e-01 | 0.948 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.497583e-02 | 1.022 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.140331e-01 | 0.943 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.643917e-02 | 1.016 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 9.970490e-02 | 1.001 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.038191e-01 | 0.984 | 1 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.832336e-02 | 1.054 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.038191e-01 | 0.984 | 1 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.084330e-01 | 0.965 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.127422e-01 | 0.948 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 9.125288e-02 | 1.040 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 9.155073e-02 | 1.038 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.082701e-01 | 0.965 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.865164e-02 | 1.052 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.165017e-01 | 0.934 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.166183e-01 | 0.933 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.196188e-01 | 0.922 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.238443e-01 | 0.907 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.240633e-01 | 0.906 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.240633e-01 | 0.906 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.260040e-01 | 0.900 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.265012e-01 | 0.898 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 1.289325e-01 | 0.890 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.289325e-01 | 0.890 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.305888e-01 | 0.884 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.305888e-01 | 0.884 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.306615e-01 | 0.884 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.335032e-01 | 0.875 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.335032e-01 | 0.875 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.335032e-01 | 0.875 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.359344e-01 | 0.867 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.359344e-01 | 0.867 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.359344e-01 | 0.867 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 1.359344e-01 | 0.867 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.369465e-01 | 0.863 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.369465e-01 | 0.863 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.384178e-01 | 0.859 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.390875e-01 | 0.857 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.403468e-01 | 0.853 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.410916e-01 | 0.850 | 1 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.411297e-01 | 0.850 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.414756e-01 | 0.849 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.414756e-01 | 0.849 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.414756e-01 | 0.849 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.414756e-01 | 0.849 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.416581e-01 | 0.849 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.427583e-01 | 0.845 | 1 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.446640e-01 | 0.840 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.446805e-01 | 0.840 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.446805e-01 | 0.840 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.467747e-01 | 0.833 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.485834e-01 | 0.828 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.485834e-01 | 0.828 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.499170e-01 | 0.824 | 1 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.530986e-01 | 0.815 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.553801e-01 | 0.809 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.561193e-01 | 0.807 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.569515e-01 | 0.804 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.605872e-01 | 0.794 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.605872e-01 | 0.794 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.605872e-01 | 0.794 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.605872e-01 | 0.794 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.605872e-01 | 0.794 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.605872e-01 | 0.794 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.616357e-01 | 0.791 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.907527e-01 | 0.720 | 0 | 0 |
| MGMT-mediated DNA damage reversal | R-HSA-5657655 | 1.907527e-01 | 0.720 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.907527e-01 | 0.720 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.907527e-01 | 0.720 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.907527e-01 | 0.720 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.720231e-01 | 0.565 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.720231e-01 | 0.565 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.720231e-01 | 0.565 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.700602e-01 | 0.769 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.700602e-01 | 0.769 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.080156e-01 | 0.682 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.080156e-01 | 0.682 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 2.080156e-01 | 0.682 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.451360e-01 | 0.462 | 0 | 0 |
| Defective ABCD1 causes ALD | R-HSA-5684045 | 3.451360e-01 | 0.462 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.451360e-01 | 0.462 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.451360e-01 | 0.462 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.451360e-01 | 0.462 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.451360e-01 | 0.462 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.451360e-01 | 0.462 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.451360e-01 | 0.462 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.467206e-01 | 0.608 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.467206e-01 | 0.608 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.467206e-01 | 0.608 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.643586e-01 | 0.784 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.643586e-01 | 0.784 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.133105e-01 | 0.671 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.133105e-01 | 0.671 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.856421e-01 | 0.544 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.856421e-01 | 0.544 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.109099e-01 | 0.386 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.109099e-01 | 0.386 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.109099e-01 | 0.386 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.109099e-01 | 0.386 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.109099e-01 | 0.386 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.109099e-01 | 0.386 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.109099e-01 | 0.386 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 4.109099e-01 | 0.386 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.109099e-01 | 0.386 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.109099e-01 | 0.386 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.849287e-01 | 0.733 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.409164e-01 | 0.618 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.062780e-01 | 0.686 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.062780e-01 | 0.686 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.062780e-01 | 0.686 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.243468e-01 | 0.489 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.243468e-01 | 0.489 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.702327e-01 | 0.769 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.147357e-01 | 0.668 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.147357e-01 | 0.668 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.508584e-01 | 0.601 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.975446e-01 | 0.526 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.975446e-01 | 0.526 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.624858e-01 | 0.441 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.624858e-01 | 0.441 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.700810e-01 | 0.328 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.700810e-01 | 0.328 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.700810e-01 | 0.328 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.700810e-01 | 0.328 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.700810e-01 | 0.328 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.700810e-01 | 0.328 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.751828e-01 | 0.757 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.261827e-01 | 0.487 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.261827e-01 | 0.487 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.261827e-01 | 0.487 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.972009e-01 | 0.527 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.972009e-01 | 0.527 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.972009e-01 | 0.527 | 1 | 1 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.972009e-01 | 0.527 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.997827e-01 | 0.398 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.997827e-01 | 0.398 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.997827e-01 | 0.398 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.997827e-01 | 0.398 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 3.997827e-01 | 0.398 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.674711e-01 | 0.776 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.729508e-01 | 0.564 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.729508e-01 | 0.564 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.729508e-01 | 0.564 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.904690e-01 | 0.720 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.520655e-01 | 0.598 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.520655e-01 | 0.598 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.548081e-01 | 0.450 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.548081e-01 | 0.450 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.337311e-01 | 0.631 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.207645e-01 | 0.494 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.930670e-01 | 0.533 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.930670e-01 | 0.533 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.930670e-01 | 0.533 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.930670e-01 | 0.533 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.153620e-01 | 0.667 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.651674e-01 | 0.576 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.651674e-01 | 0.576 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.651674e-01 | 0.576 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.444554e-01 | 0.463 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.444554e-01 | 0.463 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.832702e-01 | 0.416 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.832702e-01 | 0.416 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.832702e-01 | 0.416 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.360218e-01 | 0.360 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.360218e-01 | 0.360 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.360218e-01 | 0.360 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.360218e-01 | 0.360 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.414462e-01 | 0.617 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.339571e-01 | 0.476 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.681797e-01 | 0.434 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.976756e-01 | 0.526 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.051453e-01 | 0.515 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.051453e-01 | 0.515 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.918497e-01 | 0.407 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.710397e-01 | 0.327 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.710397e-01 | 0.327 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.710397e-01 | 0.327 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.682440e-01 | 0.571 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.965260e-01 | 0.528 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.309699e-01 | 0.480 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.205146e-01 | 0.494 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.205146e-01 | 0.494 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.391856e-01 | 0.357 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.391856e-01 | 0.357 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.478232e-01 | 0.459 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.647673e-01 | 0.438 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.516438e-01 | 0.454 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.939724e-01 | 0.532 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.673485e-01 | 0.435 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.673485e-01 | 0.435 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.387080e-01 | 0.358 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.664193e-01 | 0.331 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.062828e-01 | 0.514 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.370897e-01 | 0.359 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.496948e-01 | 0.347 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.665056e-01 | 0.331 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.665056e-01 | 0.331 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.434426e-01 | 0.353 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.403651e-01 | 0.356 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.403651e-01 | 0.356 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.883458e-01 | 0.540 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.129201e-01 | 0.672 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.062828e-01 | 0.514 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.856481e-01 | 0.731 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.576501e-01 | 0.339 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.576501e-01 | 0.339 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.905335e-01 | 0.720 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.151003e-01 | 0.502 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.856481e-01 | 0.731 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.738641e-01 | 0.562 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.665983e-01 | 0.436 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.972009e-01 | 0.527 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.548081e-01 | 0.450 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.313675e-01 | 0.636 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.134245e-01 | 0.504 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.191593e-01 | 0.378 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.751828e-01 | 0.757 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.723063e-01 | 0.326 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.783175e-01 | 0.749 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.037981e-01 | 0.691 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.546005e-01 | 0.450 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.574337e-01 | 0.447 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.444554e-01 | 0.463 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.251700e-01 | 0.488 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.817683e-01 | 0.418 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.165916e-01 | 0.380 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.045734e-01 | 0.516 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.231706e-01 | 0.651 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.599247e-01 | 0.337 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.153840e-01 | 0.382 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.959751e-01 | 0.402 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.959751e-01 | 0.402 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.936964e-01 | 0.405 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.999560e-01 | 0.523 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.716622e-01 | 0.326 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.716622e-01 | 0.326 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.007890e-01 | 0.697 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.997827e-01 | 0.398 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.997827e-01 | 0.398 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.114352e-01 | 0.386 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.710397e-01 | 0.327 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.885227e-01 | 0.540 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.370897e-01 | 0.359 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.337159e-01 | 0.631 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.339571e-01 | 0.476 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.663041e-01 | 0.779 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.720231e-01 | 0.565 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.133105e-01 | 0.671 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.409164e-01 | 0.618 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.243468e-01 | 0.489 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.508584e-01 | 0.601 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.261827e-01 | 0.487 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.207645e-01 | 0.494 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.681797e-01 | 0.434 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.546005e-01 | 0.450 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.710397e-01 | 0.327 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.617534e-01 | 0.336 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.589936e-01 | 0.445 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.360218e-01 | 0.360 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.387080e-01 | 0.358 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.793797e-01 | 0.421 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.062780e-01 | 0.686 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.282924e-01 | 0.642 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.406035e-01 | 0.619 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.752115e-01 | 0.560 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.561659e-01 | 0.448 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.962731e-01 | 0.707 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.824464e-01 | 0.549 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.561024e-01 | 0.592 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.874769e-01 | 0.541 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.752928e-01 | 0.426 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.601541e-01 | 0.585 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.601541e-01 | 0.585 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.772288e-01 | 0.751 | 1 | 0 |
| PTK6 Expression | R-HSA-8849473 | 2.856421e-01 | 0.544 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.849287e-01 | 0.733 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.243468e-01 | 0.489 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.975446e-01 | 0.526 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.975446e-01 | 0.526 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.360218e-01 | 0.360 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.360218e-01 | 0.360 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.710397e-01 | 0.327 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.391856e-01 | 0.357 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.793797e-01 | 0.421 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.936964e-01 | 0.405 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.772288e-01 | 0.751 | 1 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.009812e-01 | 0.697 | 1 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.348392e-01 | 0.629 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.056939e-01 | 0.515 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.165916e-01 | 0.380 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.976756e-01 | 0.526 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.979024e-01 | 0.400 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.009812e-01 | 0.697 | 1 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.147357e-01 | 0.668 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.664193e-01 | 0.331 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.133606e-01 | 0.384 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.874769e-01 | 0.541 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.702327e-01 | 0.769 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.671870e-01 | 0.777 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.998026e-01 | 0.699 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.968491e-01 | 0.706 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.247200e-01 | 0.648 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.247200e-01 | 0.648 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.080156e-01 | 0.682 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.643586e-01 | 0.784 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 4.109099e-01 | 0.386 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.700810e-01 | 0.328 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.738641e-01 | 0.562 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.114352e-01 | 0.386 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.979024e-01 | 0.400 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.070200e-01 | 0.390 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.581570e-01 | 0.446 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.467206e-01 | 0.608 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.975446e-01 | 0.526 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.832702e-01 | 0.416 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.387080e-01 | 0.358 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.348392e-01 | 0.629 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.409164e-01 | 0.618 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.624858e-01 | 0.441 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.561024e-01 | 0.592 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.159301e-01 | 0.381 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.327653e-01 | 0.364 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.348392e-01 | 0.629 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.396891e-01 | 0.469 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.918497e-01 | 0.407 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.334014e-01 | 0.477 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.345701e-01 | 0.630 | 1 | 0 |
| Circadian clock | R-HSA-9909396 | 2.292936e-01 | 0.640 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.134245e-01 | 0.504 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.107747e-01 | 0.508 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.673485e-01 | 0.435 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.904690e-01 | 0.720 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.207645e-01 | 0.494 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.968588e-01 | 0.527 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.751828e-01 | 0.757 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.268304e-01 | 0.644 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.636754e-01 | 0.334 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.016691e-01 | 0.396 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.907527e-01 | 0.720 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.907527e-01 | 0.720 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.720231e-01 | 0.565 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.720231e-01 | 0.565 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.451360e-01 | 0.462 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.451360e-01 | 0.462 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.451360e-01 | 0.462 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.451360e-01 | 0.462 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.451360e-01 | 0.462 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 4.109099e-01 | 0.386 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.109099e-01 | 0.386 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.109099e-01 | 0.386 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.690611e-01 | 0.570 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.624858e-01 | 0.441 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.751828e-01 | 0.757 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.997827e-01 | 0.398 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.997827e-01 | 0.398 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.894795e-01 | 0.722 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.832702e-01 | 0.416 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.360218e-01 | 0.360 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.710397e-01 | 0.327 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.710397e-01 | 0.327 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.107747e-01 | 0.508 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.793797e-01 | 0.421 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.377644e-01 | 0.624 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.831922e-01 | 0.316 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.434426e-01 | 0.353 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.315375e-01 | 0.635 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.865921e-01 | 0.729 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.456218e-01 | 0.610 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.751828e-01 | 0.757 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.997827e-01 | 0.398 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.429276e-01 | 0.354 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.258548e-01 | 0.371 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.574202e-01 | 0.340 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.770251e-01 | 0.321 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.813053e-01 | 0.551 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.546005e-01 | 0.450 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.823294e-01 | 0.317 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.508584e-01 | 0.601 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.972009e-01 | 0.527 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.832702e-01 | 0.416 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.976756e-01 | 0.526 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.387080e-01 | 0.358 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 4.844589e-01 | 0.315 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.864096e-01 | 0.313 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.166284e-01 | 0.499 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.985560e-01 | 0.400 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.804550e-01 | 0.744 | 1 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.080156e-01 | 0.682 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.624858e-01 | 0.441 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.624858e-01 | 0.441 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.348392e-01 | 0.629 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.444554e-01 | 0.463 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.251700e-01 | 0.488 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 2.856421e-01 | 0.544 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.027569e-01 | 0.693 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.592677e-01 | 0.586 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.849316e-01 | 0.545 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.379852e-01 | 0.471 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.948977e-01 | 0.404 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.625465e-01 | 0.335 | 1 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.720231e-01 | 0.565 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.080156e-01 | 0.682 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.133105e-01 | 0.671 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.700810e-01 | 0.328 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.700810e-01 | 0.328 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.348392e-01 | 0.629 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.134245e-01 | 0.504 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.959751e-01 | 0.402 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.618757e-01 | 0.335 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.817683e-01 | 0.418 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.350288e-01 | 0.361 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.080156e-01 | 0.682 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.360218e-01 | 0.360 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.492975e-01 | 0.603 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.142423e-01 | 0.503 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.856421e-01 | 0.544 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.856421e-01 | 0.544 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.109099e-01 | 0.386 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.849287e-01 | 0.733 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.700810e-01 | 0.328 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.997827e-01 | 0.398 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 3.444554e-01 | 0.463 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.374272e-01 | 0.359 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.496948e-01 | 0.347 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.564605e-01 | 0.341 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.348392e-01 | 0.629 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 2.520655e-01 | 0.598 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.168344e-01 | 0.380 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.624858e-01 | 0.441 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.243468e-01 | 0.489 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.624858e-01 | 0.441 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 4.700810e-01 | 0.328 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.710397e-01 | 0.327 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 4.617534e-01 | 0.336 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.997827e-01 | 0.398 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.832702e-01 | 0.416 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.239403e-01 | 0.650 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.360218e-01 | 0.360 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.864583e-01 | 0.729 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.089218e-01 | 0.510 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.409164e-01 | 0.618 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 4.664193e-01 | 0.331 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.833897e-01 | 0.416 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.258548e-01 | 0.371 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.897333e-01 | 0.310 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.897333e-01 | 0.310 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.908579e-01 | 0.309 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 4.920733e-01 | 0.308 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.929136e-01 | 0.307 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.930491e-01 | 0.307 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.930491e-01 | 0.307 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.930491e-01 | 0.307 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.930491e-01 | 0.307 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.930491e-01 | 0.307 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.930491e-01 | 0.307 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.930491e-01 | 0.307 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.930491e-01 | 0.307 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.962809e-01 | 0.304 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.047161e-01 | 0.297 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.047161e-01 | 0.297 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.047161e-01 | 0.297 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.047161e-01 | 0.297 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.047161e-01 | 0.297 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.047161e-01 | 0.297 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.047161e-01 | 0.297 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.047161e-01 | 0.297 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.047161e-01 | 0.297 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.047161e-01 | 0.297 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.047161e-01 | 0.297 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.047161e-01 | 0.297 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.047161e-01 | 0.297 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.047161e-01 | 0.297 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.047161e-01 | 0.297 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.047161e-01 | 0.297 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.047161e-01 | 0.297 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.047161e-01 | 0.297 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.047161e-01 | 0.297 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.067696e-01 | 0.295 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.067696e-01 | 0.295 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.075987e-01 | 0.294 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.075987e-01 | 0.294 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.075987e-01 | 0.294 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 5.075987e-01 | 0.294 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 5.075987e-01 | 0.294 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.155499e-01 | 0.288 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.160923e-01 | 0.287 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.160923e-01 | 0.287 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.190014e-01 | 0.285 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 5.190014e-01 | 0.285 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.190014e-01 | 0.285 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 5.233118e-01 | 0.281 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.233118e-01 | 0.281 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.233118e-01 | 0.281 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.233118e-01 | 0.281 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.233118e-01 | 0.281 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.233118e-01 | 0.281 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.233118e-01 | 0.281 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.233118e-01 | 0.281 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.233118e-01 | 0.281 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.233118e-01 | 0.281 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.233118e-01 | 0.281 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.233118e-01 | 0.281 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 5.233118e-01 | 0.281 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.252299e-01 | 0.280 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.308327e-01 | 0.275 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.362106e-01 | 0.271 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.362106e-01 | 0.271 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.362106e-01 | 0.271 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.362106e-01 | 0.271 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.369671e-01 | 0.270 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.369671e-01 | 0.270 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.369671e-01 | 0.270 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.369671e-01 | 0.270 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.369671e-01 | 0.270 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.384356e-01 | 0.269 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.407658e-01 | 0.267 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.426004e-01 | 0.266 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.442156e-01 | 0.264 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.442156e-01 | 0.264 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.442156e-01 | 0.264 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.482100e-01 | 0.261 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.500187e-01 | 0.260 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.500187e-01 | 0.260 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.532603e-01 | 0.257 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.550926e-01 | 0.256 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.550926e-01 | 0.256 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.550926e-01 | 0.256 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.550926e-01 | 0.256 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.550926e-01 | 0.256 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.550926e-01 | 0.256 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.550926e-01 | 0.256 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.596862e-01 | 0.252 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.596862e-01 | 0.252 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.596862e-01 | 0.252 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.639246e-01 | 0.249 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.677395e-01 | 0.246 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.677395e-01 | 0.246 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.677395e-01 | 0.246 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.677395e-01 | 0.246 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 5.686428e-01 | 0.245 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 5.686428e-01 | 0.245 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.686428e-01 | 0.245 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.686428e-01 | 0.245 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 5.686428e-01 | 0.245 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.711983e-01 | 0.243 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.711983e-01 | 0.243 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.711983e-01 | 0.243 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.711983e-01 | 0.243 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.711983e-01 | 0.243 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.711983e-01 | 0.243 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.711983e-01 | 0.243 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.711983e-01 | 0.243 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.711983e-01 | 0.243 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.711983e-01 | 0.243 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.711983e-01 | 0.243 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.711983e-01 | 0.243 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.711983e-01 | 0.243 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.711983e-01 | 0.243 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.711983e-01 | 0.243 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.711983e-01 | 0.243 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.720740e-01 | 0.243 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.768042e-01 | 0.239 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.822895e-01 | 0.235 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.851501e-01 | 0.233 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.911853e-01 | 0.228 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.911853e-01 | 0.228 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.911853e-01 | 0.228 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.916717e-01 | 0.228 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.922447e-01 | 0.227 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.922447e-01 | 0.227 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.922447e-01 | 0.227 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.922447e-01 | 0.227 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.945770e-01 | 0.226 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.964659e-01 | 0.224 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.970047e-01 | 0.224 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.970047e-01 | 0.224 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.970047e-01 | 0.224 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.970047e-01 | 0.224 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.970047e-01 | 0.224 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.970047e-01 | 0.224 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.970047e-01 | 0.224 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.970047e-01 | 0.224 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.970047e-01 | 0.224 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.970047e-01 | 0.224 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.984871e-01 | 0.223 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.082356e-01 | 0.216 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.090297e-01 | 0.215 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.094843e-01 | 0.215 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.142768e-01 | 0.212 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.142768e-01 | 0.212 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.142768e-01 | 0.212 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.142768e-01 | 0.212 | 0 | 0 |
| Metabolism of ingested MeSeO2H into MeSeH | R-HSA-5263617 | 6.142768e-01 | 0.212 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.142768e-01 | 0.212 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 6.142768e-01 | 0.212 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.142768e-01 | 0.212 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 6.142768e-01 | 0.212 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 6.149931e-01 | 0.211 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.149931e-01 | 0.211 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.240946e-01 | 0.205 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.247551e-01 | 0.204 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.247551e-01 | 0.204 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.247551e-01 | 0.204 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.247551e-01 | 0.204 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.247551e-01 | 0.204 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.247551e-01 | 0.204 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.247816e-01 | 0.204 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.247816e-01 | 0.204 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.252672e-01 | 0.204 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.265251e-01 | 0.203 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.300437e-01 | 0.201 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.300437e-01 | 0.201 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.300437e-01 | 0.201 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.368682e-01 | 0.196 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.368682e-01 | 0.196 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.368682e-01 | 0.196 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.368682e-01 | 0.196 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.368682e-01 | 0.196 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.383965e-01 | 0.195 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.383965e-01 | 0.195 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.383965e-01 | 0.195 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 6.485589e-01 | 0.188 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.485589e-01 | 0.188 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.485589e-01 | 0.188 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.490299e-01 | 0.188 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.509995e-01 | 0.186 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.509995e-01 | 0.186 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.509995e-01 | 0.186 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 6.509995e-01 | 0.186 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.523799e-01 | 0.185 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.530299e-01 | 0.185 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.530299e-01 | 0.185 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.530299e-01 | 0.185 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.530299e-01 | 0.185 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.530299e-01 | 0.185 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.530299e-01 | 0.185 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.530299e-01 | 0.185 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 6.530299e-01 | 0.185 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.530299e-01 | 0.185 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.530299e-01 | 0.185 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.530299e-01 | 0.185 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.530299e-01 | 0.185 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.530299e-01 | 0.185 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.530299e-01 | 0.185 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.530299e-01 | 0.185 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.530299e-01 | 0.185 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.530299e-01 | 0.185 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.578583e-01 | 0.182 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.578583e-01 | 0.182 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.595215e-01 | 0.181 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.595215e-01 | 0.181 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.595215e-01 | 0.181 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 6.660362e-01 | 0.177 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.697649e-01 | 0.174 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.699053e-01 | 0.174 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.721447e-01 | 0.173 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.752946e-01 | 0.171 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.757606e-01 | 0.170 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.757606e-01 | 0.170 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.757606e-01 | 0.170 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 6.757606e-01 | 0.170 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.757606e-01 | 0.170 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.757606e-01 | 0.170 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.757606e-01 | 0.170 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.779583e-01 | 0.169 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.779583e-01 | 0.169 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 6.779583e-01 | 0.169 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.779583e-01 | 0.169 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.779583e-01 | 0.169 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.833087e-01 | 0.165 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.837030e-01 | 0.165 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.839709e-01 | 0.165 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.878812e-01 | 0.162 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.878915e-01 | 0.162 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.878915e-01 | 0.162 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.878915e-01 | 0.162 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.878915e-01 | 0.162 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.878915e-01 | 0.162 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.878915e-01 | 0.162 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 6.878915e-01 | 0.162 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.878915e-01 | 0.162 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.878915e-01 | 0.162 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.878915e-01 | 0.162 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 6.878915e-01 | 0.162 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 6.878915e-01 | 0.162 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.878915e-01 | 0.162 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.878915e-01 | 0.162 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.883058e-01 | 0.162 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.888462e-01 | 0.162 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.905744e-01 | 0.161 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.905744e-01 | 0.161 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.971696e-01 | 0.157 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.990713e-01 | 0.155 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.990713e-01 | 0.155 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.990713e-01 | 0.155 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.990713e-01 | 0.155 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.990713e-01 | 0.155 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.990713e-01 | 0.155 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.003203e-01 | 0.155 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.003203e-01 | 0.155 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.003647e-01 | 0.155 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.042990e-01 | 0.152 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 7.049375e-01 | 0.152 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.053561e-01 | 0.152 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.111627e-01 | 0.148 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.120529e-01 | 0.147 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.120529e-01 | 0.147 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.125870e-01 | 0.147 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.154985e-01 | 0.145 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.154985e-01 | 0.145 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.154985e-01 | 0.145 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.154985e-01 | 0.145 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 7.162990e-01 | 0.145 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.162990e-01 | 0.145 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.192523e-01 | 0.143 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.192523e-01 | 0.143 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.192523e-01 | 0.143 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.192523e-01 | 0.143 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.192523e-01 | 0.143 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.192523e-01 | 0.143 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.192523e-01 | 0.143 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.192523e-01 | 0.143 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.192523e-01 | 0.143 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.192523e-01 | 0.143 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.192523e-01 | 0.143 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.192523e-01 | 0.143 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.192523e-01 | 0.143 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.201803e-01 | 0.143 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.209731e-01 | 0.142 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.209731e-01 | 0.142 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.209731e-01 | 0.142 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.241419e-01 | 0.140 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.241419e-01 | 0.140 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.241419e-01 | 0.140 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.241419e-01 | 0.140 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.241419e-01 | 0.140 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.292026e-01 | 0.137 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.316412e-01 | 0.136 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.329561e-01 | 0.135 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.334179e-01 | 0.135 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.334179e-01 | 0.135 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.334179e-01 | 0.135 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.367078e-01 | 0.133 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.378030e-01 | 0.132 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.407878e-01 | 0.130 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.415137e-01 | 0.130 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.453138e-01 | 0.128 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.463518e-01 | 0.127 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.463518e-01 | 0.127 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.466989e-01 | 0.127 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.466989e-01 | 0.127 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.474636e-01 | 0.126 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.474636e-01 | 0.126 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.474636e-01 | 0.126 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.474636e-01 | 0.126 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.474636e-01 | 0.126 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.474636e-01 | 0.126 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.474636e-01 | 0.126 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.474636e-01 | 0.126 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.488606e-01 | 0.126 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.495572e-01 | 0.125 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.504851e-01 | 0.125 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.557491e-01 | 0.122 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.594835e-01 | 0.119 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.594835e-01 | 0.119 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.604380e-01 | 0.119 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.604380e-01 | 0.119 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.604380e-01 | 0.119 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.604380e-01 | 0.119 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.604380e-01 | 0.119 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.607455e-01 | 0.119 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.607455e-01 | 0.119 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.607455e-01 | 0.119 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.610511e-01 | 0.119 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.629011e-01 | 0.118 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.653202e-01 | 0.116 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.683507e-01 | 0.114 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.693354e-01 | 0.114 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.717763e-01 | 0.113 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.728415e-01 | 0.112 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.728415e-01 | 0.112 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.728415e-01 | 0.112 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.728415e-01 | 0.112 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.728415e-01 | 0.112 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.728415e-01 | 0.112 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.728415e-01 | 0.112 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.728415e-01 | 0.112 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.728415e-01 | 0.112 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.728415e-01 | 0.112 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.728415e-01 | 0.112 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.728415e-01 | 0.112 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.734312e-01 | 0.112 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.739089e-01 | 0.111 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.739089e-01 | 0.111 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.787240e-01 | 0.109 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.787240e-01 | 0.109 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.787240e-01 | 0.109 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.788342e-01 | 0.109 | 1 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.802660e-01 | 0.108 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.802660e-01 | 0.108 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.828590e-01 | 0.106 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.854051e-01 | 0.105 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.867756e-01 | 0.104 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.875846e-01 | 0.104 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.944176e-01 | 0.100 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.944176e-01 | 0.100 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 7.944176e-01 | 0.100 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.955069e-01 | 0.099 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.955069e-01 | 0.099 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.955069e-01 | 0.099 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.956705e-01 | 0.099 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 7.956705e-01 | 0.099 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.956705e-01 | 0.099 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.956705e-01 | 0.099 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.956705e-01 | 0.099 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.956705e-01 | 0.099 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.956705e-01 | 0.099 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.963036e-01 | 0.099 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.963036e-01 | 0.099 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.990506e-01 | 0.097 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.003212e-01 | 0.097 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.022946e-01 | 0.096 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.034783e-01 | 0.095 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.047548e-01 | 0.094 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.057690e-01 | 0.094 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.066588e-01 | 0.093 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.078001e-01 | 0.093 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.078001e-01 | 0.093 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.078001e-01 | 0.093 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.078001e-01 | 0.093 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.078001e-01 | 0.093 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.078001e-01 | 0.093 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.078001e-01 | 0.093 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.107479e-01 | 0.091 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.107479e-01 | 0.091 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.107479e-01 | 0.091 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.107479e-01 | 0.091 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.111528e-01 | 0.091 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.111528e-01 | 0.091 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.111528e-01 | 0.091 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.151186e-01 | 0.089 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.162065e-01 | 0.088 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.162065e-01 | 0.088 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.162065e-01 | 0.088 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.162065e-01 | 0.088 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.162065e-01 | 0.088 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.162065e-01 | 0.088 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.162065e-01 | 0.088 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.204397e-01 | 0.086 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.204397e-01 | 0.086 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.204397e-01 | 0.086 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.204717e-01 | 0.086 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.209267e-01 | 0.086 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.218824e-01 | 0.085 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.218824e-01 | 0.085 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.226052e-01 | 0.085 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.261100e-01 | 0.083 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.270031e-01 | 0.082 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.285324e-01 | 0.082 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.315843e-01 | 0.080 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.323637e-01 | 0.080 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.323637e-01 | 0.080 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.323637e-01 | 0.080 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 8.346796e-01 | 0.078 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.346796e-01 | 0.078 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.346796e-01 | 0.078 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 8.346796e-01 | 0.078 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.346796e-01 | 0.078 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.346796e-01 | 0.078 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.346796e-01 | 0.078 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.392692e-01 | 0.076 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.392692e-01 | 0.076 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.392692e-01 | 0.076 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.392692e-01 | 0.076 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.392692e-01 | 0.076 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.436001e-01 | 0.074 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.436001e-01 | 0.074 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.436001e-01 | 0.074 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.436001e-01 | 0.074 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.454621e-01 | 0.073 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.512969e-01 | 0.070 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.512969e-01 | 0.070 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.512969e-01 | 0.070 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.512969e-01 | 0.070 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.512969e-01 | 0.070 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.512969e-01 | 0.070 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 8.512969e-01 | 0.070 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.512969e-01 | 0.070 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.512969e-01 | 0.070 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.512969e-01 | 0.070 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.515219e-01 | 0.070 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.518560e-01 | 0.070 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 8.518560e-01 | 0.070 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.518560e-01 | 0.070 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.518560e-01 | 0.070 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.533455e-01 | 0.069 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.541774e-01 | 0.068 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.541774e-01 | 0.068 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.541774e-01 | 0.068 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.541774e-01 | 0.068 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.541774e-01 | 0.068 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.566702e-01 | 0.067 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.582015e-01 | 0.066 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.602657e-01 | 0.065 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.635375e-01 | 0.064 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.635375e-01 | 0.064 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.635375e-01 | 0.064 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.641239e-01 | 0.063 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.641239e-01 | 0.063 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.662448e-01 | 0.062 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.662448e-01 | 0.062 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.662448e-01 | 0.062 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.662448e-01 | 0.062 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.662448e-01 | 0.062 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.662448e-01 | 0.062 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.662448e-01 | 0.062 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.662448e-01 | 0.062 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.662448e-01 | 0.062 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.662448e-01 | 0.062 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.694549e-01 | 0.061 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.710936e-01 | 0.060 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.734684e-01 | 0.059 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.734684e-01 | 0.059 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.743684e-01 | 0.058 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.743684e-01 | 0.058 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.743684e-01 | 0.058 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.774608e-01 | 0.057 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.778037e-01 | 0.057 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.796909e-01 | 0.056 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.796909e-01 | 0.056 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.796909e-01 | 0.056 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.796909e-01 | 0.056 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.796909e-01 | 0.056 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.796909e-01 | 0.056 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.796909e-01 | 0.056 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.796909e-01 | 0.056 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.796909e-01 | 0.056 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.796909e-01 | 0.056 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.822389e-01 | 0.054 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.822389e-01 | 0.054 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.822389e-01 | 0.054 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.832635e-01 | 0.054 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.833215e-01 | 0.054 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.844017e-01 | 0.053 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.844017e-01 | 0.053 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.844017e-01 | 0.053 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.858013e-01 | 0.053 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.878233e-01 | 0.052 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.888952e-01 | 0.051 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.888952e-01 | 0.051 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.904635e-01 | 0.050 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.904635e-01 | 0.050 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.917860e-01 | 0.050 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.917860e-01 | 0.050 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.917860e-01 | 0.050 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.917860e-01 | 0.050 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.917860e-01 | 0.050 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.917860e-01 | 0.050 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.927208e-01 | 0.049 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.936883e-01 | 0.049 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.936883e-01 | 0.049 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.936883e-01 | 0.049 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.967877e-01 | 0.047 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.969011e-01 | 0.047 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.981694e-01 | 0.047 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.995622e-01 | 0.046 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.022767e-01 | 0.045 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.022767e-01 | 0.045 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.026658e-01 | 0.044 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.026658e-01 | 0.044 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.026658e-01 | 0.044 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.026658e-01 | 0.044 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.026658e-01 | 0.044 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.026658e-01 | 0.044 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.031957e-01 | 0.044 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.045992e-01 | 0.044 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.053835e-01 | 0.043 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.053835e-01 | 0.043 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.060157e-01 | 0.043 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.083230e-01 | 0.042 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 9.102136e-01 | 0.041 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.121319e-01 | 0.040 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 9.121319e-01 | 0.040 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.124523e-01 | 0.040 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.124523e-01 | 0.040 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.124523e-01 | 0.040 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.124523e-01 | 0.040 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.124523e-01 | 0.040 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.124523e-01 | 0.040 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.130526e-01 | 0.040 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.131778e-01 | 0.039 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.139895e-01 | 0.039 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.145275e-01 | 0.039 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.175430e-01 | 0.037 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.175430e-01 | 0.037 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.184397e-01 | 0.037 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.184397e-01 | 0.037 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.184397e-01 | 0.037 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.212554e-01 | 0.036 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.212554e-01 | 0.036 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.212554e-01 | 0.036 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.212554e-01 | 0.036 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.212554e-01 | 0.036 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.212554e-01 | 0.036 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.243069e-01 | 0.034 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.243069e-01 | 0.034 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.243069e-01 | 0.034 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.243851e-01 | 0.034 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.247947e-01 | 0.034 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.247947e-01 | 0.034 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.247947e-01 | 0.034 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.264838e-01 | 0.033 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.282945e-01 | 0.032 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.282945e-01 | 0.032 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.291737e-01 | 0.032 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.291737e-01 | 0.032 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.291737e-01 | 0.032 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.291737e-01 | 0.032 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.291737e-01 | 0.032 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.291737e-01 | 0.032 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 9.291737e-01 | 0.032 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.291737e-01 | 0.032 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.298306e-01 | 0.032 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.305448e-01 | 0.031 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.305448e-01 | 0.031 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.305448e-01 | 0.031 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.305448e-01 | 0.031 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.314420e-01 | 0.031 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.362143e-01 | 0.029 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.362963e-01 | 0.029 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.362963e-01 | 0.029 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.362963e-01 | 0.029 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.362963e-01 | 0.029 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.362963e-01 | 0.029 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.362963e-01 | 0.029 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.362963e-01 | 0.029 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.375523e-01 | 0.028 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.414355e-01 | 0.026 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.415899e-01 | 0.026 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.415899e-01 | 0.026 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.427029e-01 | 0.026 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.427029e-01 | 0.026 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.427029e-01 | 0.026 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.427029e-01 | 0.026 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.427029e-01 | 0.026 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.440394e-01 | 0.025 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.452999e-01 | 0.024 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.464653e-01 | 0.024 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.467965e-01 | 0.024 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.482899e-01 | 0.023 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.483415e-01 | 0.023 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.483415e-01 | 0.023 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.484656e-01 | 0.023 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.484656e-01 | 0.023 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.484656e-01 | 0.023 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.484656e-01 | 0.023 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.484656e-01 | 0.023 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.530500e-01 | 0.021 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.535376e-01 | 0.021 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.536490e-01 | 0.021 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.536490e-01 | 0.021 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.536490e-01 | 0.021 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.536490e-01 | 0.021 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.536490e-01 | 0.021 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.536490e-01 | 0.021 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.536490e-01 | 0.021 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.550767e-01 | 0.020 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.583113e-01 | 0.018 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.583113e-01 | 0.018 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.583113e-01 | 0.018 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.583113e-01 | 0.018 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.583113e-01 | 0.018 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.583113e-01 | 0.018 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.584772e-01 | 0.018 | 1 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.585644e-01 | 0.018 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.585644e-01 | 0.018 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.588689e-01 | 0.018 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.588689e-01 | 0.018 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.591445e-01 | 0.018 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.606072e-01 | 0.017 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.612217e-01 | 0.017 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.623530e-01 | 0.017 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.623530e-01 | 0.017 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.623938e-01 | 0.017 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.625049e-01 | 0.017 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.625049e-01 | 0.017 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.625049e-01 | 0.017 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.625049e-01 | 0.017 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.625049e-01 | 0.017 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.632810e-01 | 0.016 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.636166e-01 | 0.016 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.661497e-01 | 0.015 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.662768e-01 | 0.015 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.662768e-01 | 0.015 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.662768e-01 | 0.015 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.662768e-01 | 0.015 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.662768e-01 | 0.015 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.684898e-01 | 0.014 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.687459e-01 | 0.014 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.687459e-01 | 0.014 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.687459e-01 | 0.014 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.696696e-01 | 0.013 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.696696e-01 | 0.013 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.696696e-01 | 0.013 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.696696e-01 | 0.013 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.711849e-01 | 0.013 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.725298e-01 | 0.012 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.725639e-01 | 0.012 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.727211e-01 | 0.012 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.727211e-01 | 0.012 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.727211e-01 | 0.012 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.727211e-01 | 0.012 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.727211e-01 | 0.012 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.736568e-01 | 0.012 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.736568e-01 | 0.012 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.746156e-01 | 0.011 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.746554e-01 | 0.011 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.754658e-01 | 0.011 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.754658e-01 | 0.011 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.759232e-01 | 0.011 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.762838e-01 | 0.010 | 1 | 1 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.765130e-01 | 0.010 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.773147e-01 | 0.010 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.779345e-01 | 0.010 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.779345e-01 | 0.010 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.779345e-01 | 0.010 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.784469e-01 | 0.009 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.784469e-01 | 0.009 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.785179e-01 | 0.009 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.788513e-01 | 0.009 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.789300e-01 | 0.009 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.801549e-01 | 0.009 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.803799e-01 | 0.009 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.804578e-01 | 0.009 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.804578e-01 | 0.009 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.816465e-01 | 0.008 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.821520e-01 | 0.008 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.821520e-01 | 0.008 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.827354e-01 | 0.008 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.828969e-01 | 0.007 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.828969e-01 | 0.007 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.831777e-01 | 0.007 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.831777e-01 | 0.007 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.847031e-01 | 0.007 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.847031e-01 | 0.007 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.853110e-01 | 0.006 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.854470e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.855638e-01 | 0.006 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.855638e-01 | 0.006 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.857022e-01 | 0.006 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.870169e-01 | 0.006 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.870169e-01 | 0.006 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.870169e-01 | 0.006 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.870169e-01 | 0.006 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.870169e-01 | 0.006 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.870169e-01 | 0.006 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.870169e-01 | 0.006 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.870169e-01 | 0.006 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.871886e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.883237e-01 | 0.005 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.883237e-01 | 0.005 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.883237e-01 | 0.005 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.883801e-01 | 0.005 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.888607e-01 | 0.005 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.894022e-01 | 0.005 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.894991e-01 | 0.005 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.894991e-01 | 0.005 | 0 | 0 |
| Translation | R-HSA-72766 | 9.901023e-01 | 0.004 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.905562e-01 | 0.004 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.905562e-01 | 0.004 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.905562e-01 | 0.004 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.905562e-01 | 0.004 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.906750e-01 | 0.004 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.915070e-01 | 0.004 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.915070e-01 | 0.004 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.919695e-01 | 0.004 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.923621e-01 | 0.003 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.931311e-01 | 0.003 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.931311e-01 | 0.003 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.933317e-01 | 0.003 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.938228e-01 | 0.003 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.939251e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.940771e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.943379e-01 | 0.002 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.944302e-01 | 0.002 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.944448e-01 | 0.002 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.944448e-01 | 0.002 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.944448e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.944667e-01 | 0.002 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.944667e-01 | 0.002 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.950043e-01 | 0.002 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.950043e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.951981e-01 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.954117e-01 | 0.002 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.955074e-01 | 0.002 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.957315e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.959599e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.959599e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.959599e-01 | 0.002 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.962930e-01 | 0.002 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.967328e-01 | 0.001 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.967328e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.968510e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.970453e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.970619e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.971373e-01 | 0.001 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.973579e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.973993e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.976170e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.976241e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.977322e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.978439e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.978439e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.979746e-01 | 0.001 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.980394e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.980787e-01 | 0.001 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.980787e-01 | 0.001 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.981688e-01 | 0.001 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.982723e-01 | 0.001 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.985269e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.985269e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.985848e-01 | 0.001 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.986030e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.986060e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.987438e-01 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.988074e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.988944e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.989055e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.989843e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.989940e-01 | 0.000 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.990867e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.991020e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.991711e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.991787e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.992615e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.992796e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.993792e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.996491e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.996845e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.996849e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.997427e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.997706e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.997706e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.997706e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.998064e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998146e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.998333e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.998432e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.998502e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998556e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998779e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.998911e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999021e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999208e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999228e-01 | 0.000 | 1 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999447e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999470e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999475e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999475e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999542e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999792e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999822e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999884e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999955e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999963e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999969e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999973e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999974e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999979e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999979e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999986e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999993e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999996e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999997e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999998e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |